Коронарография. Коронарное шунтированиею Коронарная ангиопластика.   

ПОКАЗАНИЯ К ИНТЕРВЕНЦИОННОЙ ТАКТИКЕ ИССЛЕДОВАНИЯ И ЛЕЧЕНИЯ

 


 
 

КОРОНАРНАЯ АНГИОПЛАСТИКА
Рекомендации Американской Ассоциации Сердца и Американского Кардиологического Колледжа
 
 

  ПРОДОЛЖЕНИЕ
 
                               
 
 
   
СПИСОК ЛИТЕРАТУРЫ
 
1   Gruntzig AR, Senning A, Sicgcnthaler WE  Nonoperative dilation of coronary artery
stenosis percutaneous transluminal coronary an-gioplasty N Engl J Med 1979,301 61- 8
2   Kent KM, Bentivogho LG, Block PC, et al   Percutaneous translu mmal coronary
angioplasty report from the Registry of the National Heart, Lung, and Blood Institute Am J
Cardiol 1982,49 2011-20
3   Williams DO, Riley RS, Singh AK, Most AS. Restoration of normal coronaiy hemody-
namics and myocardial metabolism after percutane-ous transluminal coronary angioplasty
Circulation 1980,62 653- 6
4   Miller DD, Verani MS Current status of myocardial perfusion imaging alter percutaneous
transluminal coronary angioplasty J Am Coll Cardiol 1994,24 260 -6
5   Detre KM, Holmes DR, Jr, Holubkov R, et al Incidence and consequences of penprocedural
occlusion   the 1985-1986 National Heart, Lung, and Blood Institute Percutaneous
Tiansluminal Coronary Angioplasty Registry Circulation 1990,82 739 -50
6   Detre KM, Holubkov R, Kelsey S, et al Percutaneous transluminal coronary angioplasty
in 1985-1986 and 1977-1981   the National Heart, Lung, and Blood Institute Registry N
Engl J Med 1988,318 265-70
7   О Keele JH, Jr, Rutherford BD, McConahay DR, et al Multivessel coronary angioplast>
from 1980 to 1989   procedural results and long-term outcome   J Am Coll Cardiol
1990,16 1097-102
8   American Heart Association  2001 Heart and Stroke Statistical Update  Dallas, TX,
American Heart Association, 2001
9   Comparison of coronary bypass surgeiy with angioplasty in patients with multivessel dis­
ease  the Bypass Angioplasty Revasculanzation Investigation (BARI) Investigators  [pub
hshed erratum appears in N Engl J Med 1997,336 147] N Engl J Med 1996,335 217-25
10  Coronary angioplasty versus coronary artery bypass surgery the Randomized Interven­
tion Treatment of Angina (RITA) trial Lancet 1993,341 573- 80
11  King SB, III, Lembo NJ, Weintraub WS, et al A randomized trial comparing coronary
angioplasty with coronary bypass surgery Emory Angioplasty versus Suigery Trial (EAST)
NEnglJ Med 1994,331   1044-50
12         Hamm CW, Reimers J, Ischinger T, Rupprecht HJ, Berger J, Bleifeld W A randomi/ed
study Ы coronary angioplasty compaied with bypass suigery in patients with s\mptomatic
multivessel coronary disease Geiman Angioplast} Bypass Surgery Investigation (GABI) N
Engl J Med 1994,331 1037-43
11 Rodriguez A, BouHon Г, Peicv-Bahno N, ct al Argentine random lzed trial of percutaneous
transluminal coionary angioplasty versus coionaiy aitery bypass surgery in multivessel disease (
ERACI) m-hospital results and 1 -year follow-up J Am Coll Cardiol 1993,22 1060-7
14        Pocock SJ, Henderson RA, Riockaids AF, et al   Meta-analysis of randomized trials
comparing coronary angioplasty with b>pass sui-gery Lancet 1995,346 1184 -9
15        American College of Cardiology-National Cardiovascular Data Registry Version 2 0
American College of Cardiology Website Available at hup //www ace oig/ncdr/cathlab htm
Accessed April 4, 2001
16        Guidelines ioi peicutaneous transluminal coionaiy angioplasty a icpoit of the American
College of Cardiology/American Heart Association Task Force on Assessment of Diagnos­tic and
Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary
Angioplasty) J Am Coll Cardiol 1993,22 2033-54
17  Detre KM, Wright E, Murphy ML, Takaro T Observer agreement in evaluating coronary
angiograms Circulation 1975,52 979-86
18   Brown BG, Bolson EL, Dodge HT Quantitative computer tech niques for analyzing coronary
aitenograms Prog Cardiovasc Dis 1986,28 403-18
19  Abdelmeguid AE, Topol EJ The myth of the myocardial 'infarctlet during percutaneous
coronary revasculanzation procedures Circula-tion 1996,94 3369 -75
20  Cahff RM, Abdelmeguid AE, Kuntz RE, et al Myonecrosis after revasculanzation pro cedures
J Am Coll Cardiol 1998,31 241-51
21   Hirshfeld JW, Jr, Ellis SG, Faxon DP, et al  ACC clinical competence statement
recommendations for the assessment and mainte-nance of proficiency in coronary intervention
procedures J Am Coll Cardiol 1998,31 722-43
22  Anderson JL Diagnostic cathetenzation and percutaneous transluminal coronary intervention
clinical datas Standards J Am Coll Cardiol 2001 In Press
23  Williams DO, Holubkov R, Yeh W, et al Percutaneous coronary intervention in the current
are compared with 1985-1986  the National Heart, Lung, and Blood Institute Registries Circulation
2000,102 2945-51
24  Jacobs AK, Kelsey SF, Yeh W, et al Documentation of decline in morbidity in women undergoing
coronary angioplasty   a report from the 1993-94 NHLBI Percutaneous Transluminal Coronary
Angioplasty Registry National Heart, Lung, and Blood Institute Am J Cardiol 1997,80 979-84
25  Roubin GS, Cannon AD, Agrawal SK, et al Intracoronary stenting for acute and threat­ened c
losure complicating percutaneous translu-minal coronary angioplasty Circulation 1992,85 916-27
26  Mark DB, Talley JD, Topol EJ, et al Economic assessment of platelet glycoprotein lib/ Ilia
inhibition for prevention of ischemic complications of high-risk coronary angioplasty EPIC
Investigators Circulation 1996,94 629 -35
27   Platelet glycoprotein Ilb/IIIa receptor blockade and low-dose hepann during percutane-
ous coronary revasculanzation the EPILOG Inves-tigators N Engl J Med 1997,336 1689 -96
28  Randomised placebo-controlled and balloon angioplasty controlled trial to assess safety
of coronaiу stenting with use of platelet glycoprotein Ilb/IIIa blockade The EPISTENT
Investigators Eval uation of Platelet ПЬЯПа Inhibitor for Stenting Lancet 1998,352 87-92
29  Ellis SG, Cowley MJ, Whitlow PL, et al Prospective case-control comparison of percutaneous t
ransluminal coronary revasculanzation in patients with multivessel disease treated in 1
986-1987 versus 1991   improved m-hospital and 12-month results  Multivessel An
gioplasty Prognosis Study (MAPS) Group J Am Coll Cardiol 1995,25 1137- 42
30  Leon MB, Bairn DS, Popma JJ, et al A clinical trial comparing three antithrombotic
drug regimens after coronary artery stenting Stent Anticoagulation Restenosis Study Investigators
N Engl J Med 1998 339 1665-71
31   Fischman DL, Leon MB, Bairn DS, et al A randomized comparison ot coronary stent
placement and balloon angioplasty in the treatment oi coronary artery disease Stent
Restenosis Study Investigators N Engl J Med 1994,331 496 -501
32  Seiruys PW de Jaegcre P, Kiemeneij F, et al A comparison of balloon expandable-stent
implantation with balloon angioplasty in patients with coronary artery disease 
Bcnestent Stud) Gioup N Fngl J Med 1994,331 489 -95
33   Fishman NW Kennard ED, Steenkiste AR, Popma JJ, Bairn DS Detie KM
New Ap-pioachcs to Coionary Intervention (NACf) registry  history and methods  Am J Cardiol
1997  80 10K-8K
34   Baim DS, Cutlip DE, Sharma SK, et al  Final results of the Balloon vs   Optimal
Athercttom> Tual (BOAT) Circulation 1998,97 322-31
35  Rankm JM, Spinelli JJ, Carere RG, et al Improved clinical outcome after widespread
use of coronary aitcry stentmg in Canada N Engl J Med 1999,341 1957- 65
36   Hen man J  von Birgclcn С Jeremias A, Schmermund A, Volbracht L Sack S
Higher iate of myocardial microinfarction by coronary stentmg and rotational atherectomy
than by balloon angioplasty (abstr) Circulation 2000,100 Suppl 1456
37  King SB Yeh W Holubkov R, et al Balloon angioplasty versus new device intervention
clinical outcomes A comparison of the NHLBIPTCA and NACI registries J Am Coll
Cardiol 1998  3 1 558-66
38  Feit F, Brooks MM, Sopko G, et al Long-term clinical outcome in the Bypass
Angioplast} Re\asui]ari7ation Investigation Registry   comparison with the randomized trial  
BARI Investigators Circula tion 2000,101 2795-802
39   McGiath PD  Malenka DJ, Wennberg DE, et al  Changing outcomes in pcicutaneous
coronary interventions  a study of 34,752 procedures in northern New England, 1990 to
1997   Northein New England Cardiovascular Disease Study Group  J Am Coll Cardiol
1999 34 674 -80
40  Grassman ED Johnson SA, Krone RJ Predictors of success and major complications
for primary percutaneous transluminal coronary angioplasty in acute myocardial infarction
an analysis ol the 1990 to 1994 Society foi Cardiac Angiography and Interventions iegistnes
J Am Coll Cardiol 1997,30 201- 8
41   Marks DS, Mensah GA, Kennard ED, Detre K, Holmes DRJ Race, baseline characteristics,
and clinical outcomes after coronary intervention The New Approaches in Coionary Inter­ventions
(NACI) legistry Am Heart J 2000,140 162-9
42  Holmes DR, Jr, Berger PB, Garratt KN, et al Application of the New York State PTCA
mortality model in patients undergoing stent implantation Circulation 2000,102 517-22
43  Hannan FL Racz M, Ryan TJ, et al Coronary angioplasty volume outcome relationsnips 
 hospitils and cardiologists JAMA 1997 277 892-98
44  Petci4)n ED I ansky AJ Anstrom KJ et al Evolving trends in intervcntional device use and
outcomes  results from the National Cardiovascular Netwoik Database Am Heait J
2000  139 198-207
45   King SB   III  Ten year completed follow up of percutaneous transluminal coronaiy
angioplasty the early Zurich experience J Am Coll Cardiol 1993,22 353- 60
46  Holmes DR   Jr   Kip KE, Kelsey SF, Detre KM, Rosen AD Cause of death analysis
in the NHLBI PTCA Registry  results and consideiations for evaluating long term survival after
coionary mtciventions J Am Coll Cardiol 1997 30 881-7
47  Influence of diabetes on 5 year mortality and morbidity in a randomi/ed trial comparing
CABG and PTCA in patients with multivessel disease   the B\pass Angioplasty Revasculan/ation
Investigation (BARI) Circulation 1997 96 1761-69
48  Detre KM, Guo P, Holubkov R, et al Coronary revasculanzation in diabetic patients a
comparison o\ the randomized and observational components of the Bypass Angioplasty
Revasculanzation Investiga tion (BARI) Circulation 1999,99 633-40
49   Kelsey SF, James M, Holubkov AL, Holubkov R, Cowley MJ, Detre KM Results of
percutaneous transluminal coronary angioplasty in women 1985-1986 National Heart,
Lung, and Blood Institute's Coronary Angioplasty Registry Circulation 1993,87 720 -7
50   Holmes DR, Jr, Detre KM, Williams DO, et al Long-term outcome of patients with
depressed left ventricular function under going percutaneous transluminal coronary angioplasty
the NHLBI FTC A Registry Circulation 1993,87 21-9
51   Popma JJ, Califf RM, Topol EJ Clinical trials of restenosis after coronary angioplasty
Circulation 1991,84 1426-36
52  Schwartz L, Bourassa MG, Lesperance J, et al Aspinn and dipyndamole in the preven­tion
of restenosis after percutaneous translumi-nal coronary angioplasty N Engl J Med 988,318 1714-9
53   Ellis SG, Roubin GS, Wilentz J, Douglas JSJ, King SB, HI Effect of 18- to 24 hour
hepann administration for prevention of restenosis after uncomplicated coronary angioplasty
Am Heart J 1989,117 777-82
54  Pepine CJ, Hirshfeld JW, MacDonald RG, et al A controlled trial of corticosteroids to
prevent restenosis after coronary angioplasty M HEART Group Circulation 1990,81 1753-61
55  Serruys PW, Rutsch W, Heyndnckx GR, et al Prevention of restenosis after percutane
ous translummal coronary angioplasty with thromboxane A2-receptor blockade a randomized,
double blind, placebo controlled trial Coronary Artery Restenosis Prevention on Repeated T
hiomboxane Antagonism Study (CARPORT) Circula-tion 1991,84 1568-80
56  O'Keefe JH Jr, McCalhster BD, Bateman TM, Kuhnlem DL, Ligon RW, Hartzler GO
Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty J Am
Coll Cardiol 1992,19 1597-600
57  Does the new angiotensin converting enzyme inhibitor cilazapnl prevent restenosis
after percutaneous transluminal coronary angioplasty9 Results of the MERCATOR study  
a multicenter, randomized, double-blind placebo-controlled trial   Multicenter Euiopean
Research lnal with Cilazapnl after Angioplasty to Prevent Translu minal Coronary
Ob­struction and Restenosis (MERCATOR) Study Group Circulation 1992 86 100 -10
58  Topol EJ, Leya F, Pinkerton CA, et al A comparison of directional atherectomy
with coronary angioplasty in patients with coronary artery disease the CAVEAT Study
Group N Engl J Med 1993,329 221-7
59   Adelman AG, Cohen EA, Kimball BP, et al A comparison of directional atherectomy
with balloon angioplasty lor lesions of the left anterior descending coronary artery N Engl
J Med 1993,329 228-33
60   Serruys PW, Klein W, Tijssen JP, et al  Evaluation of ketansenn in the prevention
of restenosis after percutaneous transluminal coronary angioplasty  a multicenter randomized
double blind placebo contiolled trial Cnculation 1993,88 1588 -601
61   Faxon DP, Spiro ТЕ, Minor S, et al  Low molecular weight hepann in prevention oi
lestenosis alter angioplasty  results of Enoxapann Restenosis (ERA) Trial  Circulation
1994 90 908-14
62  Leaf A, Jorgensen MB, Jacobs AK, et al Do fish oils prevent restenosis after coronary
angioplasty? Circulation 1994,90 2248 -57
63   Weintiaub WS, Boccuzzi SJ, Klein JL, et al Lack of effect of lovastatin on restenosis
after coronary angioplasty  Lovastatin Resten-osis Trial Study Group   N Engl J Med 1994,
331 1331-7
64  Watanabe K, Sekiya M, Ikeda S, Miyagawa M, Hashida К Preven-tive eflects of probucol
on restenosis after percutaneous transluminal coronary angioplasty Am Heart J 1996,132 23-9
65   Tardil JC, Cote G, Lesperance J, et al Probucol and multivitamms in the prevention of
restenosis after coronaiy angioplasty Multivitamms and Probucol Study Group N Engl J Med
1997,337 365-72
66  Senuys PW van Hout B, Bonnier H, et al Randomised comparison of implantation
of hepann-coated stents with balloon angioplasty in selected patients with coronary artery
dis­ease (Benestent II) [pub-hshed erratum appears in Lancet 1998,352 1478] Lancet 1998,352 673-81
67   Tamai H, Katoh O, Suzuki S, et al  Impact of tramlast on restenosis after coronary
angioplasty   tramlast restenosis following angioplasty trial (TREAT)   Am Heart J
1999.138 968-75
68  Holmes D, Fitzgerald P, Goldberg S, et al The PRESTO (Prevention of restenosis
with tranilast and its outcomes) protocol  a double-blind, placebo-controlled trial Am Heart J
2000.139 23-31
69  Haudenschild CC Pathobiology of restenosis after angioplasty Am J Med 1993,94 40S-44S
70  Currier JW, Haudenschild C, Faxon DP Pathophysiology of resten-osis clinical
implica­tions In Ischinger T, Gohlke H, editors Strategies in Primary and Secondary Prevention
of Coronary Artery Disease W Zuckschwerdt, Verlag, 1992,181-192
71   Mmtz GS, Popma JJ, Pichard AD, et al Arterial remodeling after coronary angioplasty
a serial intravascular ultrasound study Circu-lation 1996,94 35-43
72  Currier JW, Faxon DP Restenosis after percutaneous transluminal coronary angioplasty
have we been aiming at the wrong target9 J Am Coll Cardiol 1995,25 516-20
73  Kuntz RE, Bairn DS Defining coronary restenosis newer clinical and angiographic
para­digms Circulation 1993,88 1310-23
74  Kuntz RE, Gibson CM, Nobuyoshi M, Bairn DS Generalized model of restenosis a
fter conventional balloon angioplasty, stenting and directional atherectomy J Am Coll
Caidiol 1993,21 15-25
75   Blackshear JL  O'Callaghan WG, Cahff RM Medical approaches to prevention of
restenosis after coionary angioplasty J Am Coll Cardiol 1987,9 834 -48
76  Bresee S J, Jacobs AK, Garber GR, et al Prior restenosis predicts restenosis after
coronary angioplast} of a new significant narrowing Am J Cardiol 1991,68 1158-62
77   Hirshfeld JW, Jr, Schwartz JS, Jugo R, et al Restenosis after coronary angioplasty
a multivanate statistical model to relate lesion and procedure variables to restenosis The
M-HEART Investigators J Am Coll Cardiol 1991,18 647-56
78  Popma JJ, Heuser R, Suntharahngam M, et al Late clinical and angiographic outcomes
after use of 90/Sr/90Y beta radiation for the treatment of m-stent restenosis Results
from the Stents and Radia-tion Therapy (START) Trial (absti) J Am Coll Cardiol 2000,
Final Pro­gram 54
79  Leon MB, Moses JW, Lansky AJ, et al Intracoronary gamma radiation for the prevention
of recurrent m-stent restenosis final results from the Gamma-1 trial (abstr) Circulation
1999,100 Suppl 175
80  Waksman R, White RL, Chan RC, et al Intracoronary gamma-radiation therapy after angioplasty
inhibits recurrence in patients with m-stent restenosis Circulation 2000,101 2165-71
81      Teirstein PS, Massullo V, Jam S, et al Catheter-based radiotherapy to inhibit restenosis
after coronary stenting N Engl J Med 1997,336 1697-703
 
82   Waksman R, Bhargava B, Chan C, et al Late total occlusions following intracoronary
radiation therapy for patients with m-stent restenosis (abstr) J Am Coll Cardiol 2000,36
Suppl 65- 8
83       King SB, III, Williams DO, Chougule P, et al Endovascular beta-radiation to reduce
restenosis after coronary balloon angioplasty results of the Beta Energy Restenosis Trial
(BERT) Circulation 1998,97 2025-30
84   Continued benefit of coronary stenting versus balloon angioplasty one-year clinical fol­
low-up of Benestent trial Benestent Study Group J Am Coll Cardiol 1996,27 255- 61
85       Penn IM, Ricci DR, Almond DG, et al Coronary artery stenting reduces restenosis final
results from the Trial of Angioplasty and Stents in Canada (TASC) I (abstr) Circulation
2000,92 Suppl 11279
86   Versaci F, Gaspardone A, Tomai F, Crea F, Chiariello L, Gioffre PA A comparison of
coronary artery stenting with angioplasty for isolated stenosis of the proximal left antenor
descending coronary artery N Engl J Med 1997,336 817-22
87       George CJ, Bairn DS, Bnnker JA, et al One-year follow-up of the Stent Restenosis
(STRESS I) Study Am J Cardiol 1998,81 860 -5
88   Rodriguez A, Ayala F, Bernardi V, et al Optimal Coronary Balloon Angioplasty with
provisional Stenting versus primary stent (OC-BAS) immediate and long-term follow-up
results J Am Coll Cardiol 1998,32 1351-7
89   Lincoff AM, Cahff RM, Mohterno DJ, et al Complementary clinical benefits of coronary
artery stenting and blockade of platelet glyco-protem Ilb/IIIa receptors Evaluation of Plate­
let Ilb/IIIa Inhibition in Stenting Investigators N Engl J Med 1999,341 319 -27
90   Betriu A, Masotti M, Serra A, et al Randomized comparison of coronary stent implantation
and balloon angioplasty in the treatment of de novo coronary artery lesions (START) a four-
year follow-up J Am Coll Cardiol 1999,34 1498 -506
91       Weaver WD, Reisman MA, Griffin JJ, et al Optimum percutaneous transluminal coronary
angioplasty compared with routine stent strategy trial (OPUS-1) a randomised trial Lancet
2000,355 2199-203
92   Al Suwaidi J, Berger PB, Holmes DR, Jr Coronary artery stents JAMA 2000,284 1828
-36
93   Ellis SG, Roubin GS, King SB, III, et al Angiographic and clinical predictors of acute
closure after native vessel coronary angioplasty Circulation 1988,77 372-9
94   Ellis SG, Vandormael MG, Cowley MJ, et al Coronary morphologic and clinical deter­
minants of procedural outcome with angioplasty for multivessel coronary disease implica­
tions for patient selection Mul-tivessel Angioplasty Prognosis Study Group Circulation
1990,82  1193-202
95   Hartzler GO, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV "High-risk"
percutaneous transluminal coronary angio-plasty Am J Cardiol 1988,61 33G-7G
96  Gaul G, Hollman J, Simpfendorfer C, Franco I Acute occlusion in multiple lesion coronary
angioplasty frequency and management J Am Coll Cardiol 1989,13 283- 8
97  Ellis SG, Roubin GS, King SB, III, et al In-hospital cardiac mortality after acute closure
after coronary angioplasty analysis of risk factors from 8,207 procedures J Am Coll Cardiol
1988,11  211-6
98  Guidelines for percutaneous transluminal coronary angioplasty a report of the American
College of Cardiology/American Heart Association Task Force on Assessment of
Diagnostic and Therapeu tic Cardiovascular Procedures (Subcommittee on Percutaneous
Transluminal Coronary Angioplasty) J Am Coll Cardiol 1988,12 529^5
99   de Feyter PJ, van den Brand M, Laarman GJ, et al  Acute coronary artery occlusion
during and after percutaneous transluminal coronary angioplasty  frequency, prediction,
clinical course, management, and follow-up [published erratum appears in Circulation
1991,84 446] Circulation 1991,83 927-36
100  Myler RK, Shaw RE, Stertzer SH, et al Lesion morphology and coronary angioplasty
current experience and analysis J Am Coll Cardiol 1992,19 1641-52
101   Kastrati A, Schomig A, Elezi S, et al Prognostic value of the modified American
College of Cardiology/American Heart Associ-ation stenosis morphology classification
for long-term angiographic and clinical outcome after coronary stent placement Circulation
1999,100 1285-90
102  Tan KH, Sulke N, Taub N, Sowton E Clinical and lesion morpho-logic determinants
of coronary angioplasty success and complications  current experience J Am Coll
Cardiol 1995,25 855-65
103  Kimmel SE, Berlin JA, Strom BL, Laskey WK Development and validation of simph
fied piedictive index for major complications in contemporary percutaneous transluminal
coronary angioplasty practice the Registry Committee of the Society for Cardiac
Angiography and Interventions J Am Coll Cardiol 1995,26 931- 8
104   Tahercio CP, Vlietstra RE, Fisher ID, Burnett JC  Risks for renal dysfunction
with cardiac angiography Ann Intern Med 1986,104 501-4
105  Ellis SG, Myler RK, King SB III, et al Causes and correlates of death after unsupported
coronary angioplasty implications for use of angioplasty and advanced support techniques
in high-risk settings Am J Cardiol 1991,68 1447-51
106   Block P, Peterson E, Krone R, et al Identification of variables needed to risk adjibt
outcome of coronary interventions evidence based guidelines for efficient data collection
J Am Coll Cardiol 1998 ^2 275-82
107   Bergelson BA, Jacobs AK, Cupples LA  et ai  PiediU'on oi risk lor hemodynamic
compiomist during percutaneous transluminal coronary angioplasty  Am J Caidiol 1992,70 1540-5
108  Cahff RM, Phillips HR, III, Hindman VIC, et al Prognostic value of a coronary arteriopardy
score J Am Coll Cardiol 1985,5 1055- 63
109  Holmes DR , Jr, Holubkov R, Vlietstra RE, et al Comparison of complications during
percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986
the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coionary Angioplasty
Registry J Am Coll Cardiol 1988,12 1149-55
110  Sinclair IN, McCabc CH, Sipperly ME, Bairn DS Predictors, therapeutic options and long
term outcome of abrupt leclosure Am J Cardiol 1988,61 61G-6G
111  Bell MR, Holmes DRJ, Berger PB, Garratt KN, Bailey KR, Gersh BJ The changing in-
hospital mortality of women undergoing percutaneous transluminal coronary angioplasty
JAMA 1993,269 2091-5
112  Cowley MJ, Mulhn SM, Kelsey SF, et al Sex differences in early and long-term results
of coronary angioplasty in the NHLBI PTCA Registry Circulation 1985,71 90 -7
113  McEniery PT, Hollman J, Knezinek V, et al Comparative safety and efficacy of percu­
taneous transluminal coronary angioplasty in men and in women Cathet Cardiovasc Diagn
1987,13 364-71
114  Kahn JK, Rutherford BD, McConahay DR, et al Comparison of procedural results and
risks of coronary angioplasty in men and women for conditions other than acute myocardial
infarction Am JCardiol 1992,69 1241-2
115  Davis KB, Chaitman B, Ryan T, Bittner V, Kennedy JW Comparison of 15-year sur­
vival for men and women after initial medical or surgical treatment for coronary artery dis­
ease a CASS registry study Coronary Artery Surgery Study J Am Coll Cardiol 1995,25 1000
-9
116  Mendes LA, Davidoff R, Cupples LA, Ryan TJ, Jacobs AK Congestive heart failure in
patients with coronary artery disease the gender paradox Am Heart J 1997,134 207-12
117  Malenka DJ, O'Connor GT, Quinton H, et al Differences in outcomes between women
and men associated with percutaneous transluminal coronary angioplasty A regional pro­
spective study of 13,061 procedures Northern New England Cardiovascular Disease Study
Group Circulation 1996,94 1199 -104
118  Kornowski R, Lansky AJ, Mintz GS, et al Comparison of men versus women in cross-
sectional area luminal narrowing, quantity of plaque, presence of calcium in plaque, and
lumen location in coronary arteries by intravascular ultrasound in patients with stable angina
pectons Am JCardiol 1997,79 1601-5
119  Greenberg MA, Mueller HS Why the excess mortality in women after PTC A? Circula­
tion 1993,87 1030-2
120  Jacobs AK, Kelsey SF, Brooks MM, et al Better outcome for women as compared to
men undergoing coronary revasculanzation   a report from the Bypass Angioplasty
Revasculanzation Investigation (BARI) Circulation 1998,98 1279-85
121  Movsowitz HD, Emmi RP, Manginas A, et al Directional coronary atherectomy in
women compared with men Chn Cardiol 1994,17 597-602
122  Bell MR, Grill DE, Garratt KN, Berger PB, Gersh BJ, Holmes DR, Jr Long-term out­
come of women compared with men after success-ful coronary angioplasty Circulation
1995 91 2876-81
123   Weintraub WS, Wenger NK, Kosinski AS, et al Percutaneous transluminal coronary
angioplasty in women compared with men J Am Coll Cardiol 1994,24 81-90
124  Robertson T, Kennard ED, Mehta S, et al Influence of gender on m-hospital clinical
and angiographic outcomes and on one-year follow-up in the New Approaches to Coronary
Intervention (NACI) registry Am J Cardiol 1997,80 26K-39K
125  Thompson RC, Holmes DR Jr, Gersh BJ, et al Percutaneous transluminal coronary
angioplasty in the elderly early- and long-term results J Am Coll Cardiol 1991,17 1245-50
126  Taddci CFG, Wcmtraub WS, Douglas JS , Jr, et al Influence of age on outcome after
percutaneous transluminal coronary angioplasty Am J Cardiol 1999 84 245-51
127  Tsai TP, Chaux A, Kass RM, et al Aortocoronary bypass surgery in septuagenarians
and octogenarians J Cardiovasc Surg (Torino) 1989, 30 364 -8
128  Holt GW, Sugrue DD, Bresnahan JF, et al Results of percutaneous transluminal coronary
angioplasty for unstable angina pectons in patients 70 years of age and older Am J Cardiol
1988,61 994-7
129  Simpfendorfer C, Raymond R, Schraider J, et al Early- and long-term results of
percu­taneous transluminal coronary angioplasty in patients 70 years of age and older with
angina pectons Am J Cardiol 1988,62 959 -61
130  Gaxiola E, Vhetsra R, Browne KF, et al Is the outcome of coronary stenting worse in
elderly patients? J Interven Cardiol 1998,11 37- 40
131  Ternn ML, Williams DO, Kleiman NS, et al Two- and three-year results of the Throm-
bolysis In Myocardial Infarction (TIMI) Phase II clinical trial  J Am Coll Cardiol 1993,22 1763-72
132  Aguirre FV, Younis LT, Chaitman BR, et al Early and 1-year clinical outcome of pa­tients
evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis results from
the TIMI II Study Circulation 1995,91 2541-48
133  Marso SP, Lincoff AM, Ellis SG, et al Optimizing the percutaneous interventional
outcomes for patients with diabetes melhtus results of the EPISTENT (Evaluation of plate­let
Ilb/IIIa inhibitor for stenting trial) diabetic substudy Circulation 1999,100 2477- 84
134  Dorros G, Lewin RF, Mathiak LM Coronary angioplasty in patients with prior coronary
artery bypass surgery  all prior coronary artery bypass surgery patients and patients
more than 5 years after coronary bypass surgery Cardiol Chn 1989,7 791- 803
135   Plokker HW, Meester BH, Serruys PW The Dutch experience in percutaneous transluminal
angioplasty of narrowed saphenous veins used for aortocoronary arterial by­pass Am
J Cardiol 1991,67 361- 6
136  Webb JG, Myler RK, Shaw RE, et al Coronary angioplasty after coronary bypass
sur­gery initial results and late outcome in 422 patients J Am Coll Cardiol 1990,16 812-20
137  Mathew V, Clavell AL, Lennon RJ, Grill DE, Holmes DR, Jr Percutaneous coronary
interventions in patients with prior coronary artery bypass graft surgery changes in patient
characteristics and outcome during two decades Am J Med 2000,108 127
138  Bhatt DL, Topol E Percutaneous coronary intervention for patients with prior bypass
surgery therapy in evolution Am J Med 2000,108  176
139  Savage MP, Douglas JSJ, Fischman DL, et al Stent placement compared with
balloon angioplasty for obstructed coronary bypass grafts   Saphenous Vein De Novo
Trial Investigators N Engl J Med 1997,337 740 -7
140  Holmes DR , Jr, Topol EJ, Cahff RM, et al A multicenter, randomized trial of coronary
angioplasty versus directional atherec-tomy for patients with saphenous vein bypass
graft lesions CAVEAT-II Investigators Circulation 1995,91 1966-74
141  Pomerantz RM, Kuntz RE, Carrozza JP, et al Acute and long-term outcome of
narrowed saphenous venous grafts treated by endoluminal stenting and directional
atherectomy Am J Cardiol 1992 70 161-7
142  Wong SC, Bairn DS, Schatz RA, et al Immediate results and late outcomes after
stent implantation in saphenous vein graft lesions the multicenter U S Palmaz-Schatz
stent expe­rience The Palmaz-Schatz Stent Study Group J Am Coll Cardiol 1995,26 704 -12
143  Brener SJ, Ellis SG, Apperson-Hansen C, Leon MB, Topol EJ Comparison of stenting
and balloon angioplasty for narrowings in aortocoronary saphenous vein conduits in place
for more than five years Am J Cardiol 1997,79 13- 8
144  Crowley ST, Bies RD, Morrison DA Percutaneous transluminal angioplasty of internal
mammary arteries in patients with rest angina Cathet Cardiovasc Diagn 1996,38 256 -62
145  Lope/ JJ, Ho KK, Stoler RC, et al Percutaneous treatment of protected and unprotected
left main coronary stenoses with new devices immediate angiographic results and interme­
diate-term follow-up J Am Coll Cardiol 1997,29 345-52
146  Teirstein PS, Warth DC, Haq N, et al High speed rotational coronary atherectomy for
patients with diffuse coronary artery disease J Am Coll Cardiol 1991,18 1694 -1701
147  Sharma SK, Dan gas G, Mehran R, et al Risk factors for the development of slow flow
during rotational coronary atherectomy Am J Cardiol 1997,80 219 -22
148  Dehmer GJ, Nichols TC, Bode AP, et al Assessment of platelet activation by coronary
sinus blood sampling during balloon angioplasty and directional coronary atherectomy Am
J Cardiol 1997,80 871-7
149  Koch КС, vom DJ, Kleinhans E, et al Influence of a platelet GP ПЬЯПа receptor an­
tagonist on myocardial hypoperfusion during rotational atherectomy as assessed by myocar-
dial Tc-99m sestamibi scmtigraphy J Am Coll Cardiol 1999,33 998 -1004
150  Bhatt DL, Lincoff AM, Cahff RM, et al The benefit of abciximab in percutaneous
coronary revasculanzation is not device-specific Am J Cardiol 2000,85 1060 -64
151  Ellis SG, Ajluni S, Arnold AZ, et al Increased coronary perforation in the new device
era incidence, classification, management, and outcome Circulation 1994,90 2725-30
152  Ajluni SC, Glazier S, Blankenship L, O'Neill WW, Safian RD Perforations after percu-­
taneous coronary interventions clinical, an-giographic, and therapeutic observations Cathet
Cardiovasc Diagn 1994,32 206 -12
153  Vogel RA, Tommaso CL, Gundry SR Initial experience with coronary angioplasty and
aortic valvuloplasty using elective semiper-cutaneous cardiopulmonary support Am J Cardiol
1988,62 811-3
154 Shawl FA, Domanski MJ, Hernandez TJ, Punja S   Emergency percutaneous
cardiopulmonary bypass support m cardiogenic shock from acute myocardial infarction Am
J Cardiol 1989,64 967-70
155  Anwar A, Mooney MR, Stertzer SH, et al Intra-aortic balloon counter pulsation sup­
port for elective coronary angioplasty in the setting of poor left ventricular function a two
center experience J Invas Cardiol 1990,2 175-80
156 Kreidieh I, Davies DW, Lim R, et al  High-nsk coronary angioplasty with elective
intraaortic balloon pump support IntJ Cardiol 1992,35 147-52
157 Loop FD, Lytle BW, Cosgrove DM, et al Influence of the internal mammary artery
graft on 10 year survival and other cardiac events N Engl J Med 1986,314 1- 6
158 Kshettry VR, Flavin TF, Emery RW, Nicoloff DM, Arom KV, Petersen RJ Does
multivessel, off-pump coronary artery bypass reduce postoperative morbidity7 Ann Thorac
Surg 2000,69 1725-30
159 Alderman EL, Bourassa MG, Cohen LS, et al Ten-year follow-up of survival and myocar­
dial infarction in the randomized Coronary Artery Surgery Study Circulation 1990,82 1629 -46
160  Eighteen year follow-up in the Veterans Affairs Cooperative Study of Coronary Artery
Bypass Surgery for stable angina the VA Coronary Artery Bypass Surgery Cooperative Study
Group Circulation 1992 86 121-30
161   Danchin N, Brengard A, Ethevenot G, et al Ten year follow up of patients with single
vessel coronary artery disease that was suitable for percutaneous transluminal coronary
angioplasty Br Heart J 1988,59 275-9
162   Hueb WA, Bellotti G, de Oliveira SA, et al The Medicine, Angioplasty or Surgery Study
(MASS) a prospective, randomized trial of medical therapy, balloon angioplasty or
bypass surgery for single proximal left anterior descending artery stenoses J Am Coll
Cardiol 1995,26 1600-5
163  Goy JJ, Eeckhout E, Burnand B, et al Coronary angioplasty versus left internal
mammary artery grafting for isolated proximal left anterior descending artery stenosis 
Lancet 1994,343 1449-53
164   Rodriguez A, Mele E, Peyregne E, et al  Three-year follow-up of the Argentine
Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary
Artery Bypass Surgery in Multivessel Disease (ERACI) J Am Coll Cardiol 1996,27 1178 -84
165  Acute platelet inhibition with abciximab does not reduce m-stent restenosis (ERASER
study) The ERASER Investigators Circulation 1999,100 799-806
166  Serruys PW, Unger F, van Hout В A, et al Comparison of coronary artery bypass sur­gery
and stenting for the treatment of multivessel disease N Engl J Med 2001 In Press
167   First-year results of CABRI (Coronary Angioplasty versus Bypass Revasculansation
Investigation) CABRI Trial Participants Lancet 1995,346 1179-84
168  Carrie D, Elbaz M, Puel J, et al Five-year outcome after coronary angioplasty
versus bypass surgery in multivessel coronary artery disease results from the French
Monocentnc Study Circulation 1997,96111-6
169  Weintraub WS, Stein B, Kosinski A, et al Outcome of coronary bypass surgery
versus coronary angioplasty in diabetic patients with multivessel coronary artery disease
J Am Coll Cardiol 1998,31 10-9
170  Rozenman Y, Sapozmkov D, Mossen M, et al Long-term angiographic follow-up
of coronary balloon angioplasty in patients with diabetes melhtus a clue to the explanation
of the results of the BARI study Balloon Angioplasty Revascularization Investigation J
Am Coll Cardiol 1997,30 1420-5
171 Hlatky MA, Rogers WJ, Johnstone I, et al Medical care costs and quality of life
after randomization to coronary angioplasty or coronary bypass surgery  Bypass
Angioplasty Revasculanzation Investigation (BARI) Investigators N Engl J Med 1997,336 92-9
172  Parisi AF, Folland ED, Hartigan P A comparison of angioplasty with medical
therapy in the treatment of single-vessel coronary artery disease Veterans Affairs
ACME Investigators N Engl J Med 1992,326 10 -6
173  Coronary angioplasty versus medical therapy for angina the second Randomised
Interven­tion Treatment of Angina (RITA-2) trial RITA-2 trial participants Lancet 1997,350 461- 8
174   Pitt B, Waters D, Brown WV, et al Agressive lipidlowenng therapy compared
with angioplasty in stable coronary artery disease Atorvastatin versus Revascularization
Treat­ment Investigators N Engl J Med 1999,341 70 -6
175  Folland ED, Hartigan PM, Parisi AF Percutaneous transluminal coronary
angioplasty versus medical therapy for stable angina pectons outcomes for patients
with double-vessel versus single-vessel coronary arteiy disease in a Veterans Affairs
Cooperative randomized trial Veterans Affairs ACME Investigators J Am Coll Cardiol 1997 29 1505-11
176   Davies RF, Goldberg AD, Forman S, et al Asymptomatic Cardiac Ischemia Pilot (ACIP)
study two-year follow-up outcomes of patients randomized to initial strategies of medical
therapy versus revascularization Circulation 1997,95 2037-43
177   Nakik HA, Kleiman NS, Farmer JA, et al Intensive medical therapy versus coronary
angioplasty for suppression of myocaidial ischemia in survivors of acute myocardial infarction
a prospective, randomized pilot study Circulation 1998,98 2017-23
178   Coronary Artery Surgery Study (CASS) a randomized trial of coronary artery bypass
surgery  quality of life m patients randomly assigned to treatment groups  Circulation
1983,68 951-60
179  Eleven-year survival in the Veterans Administration randomized trial of coronary by­
pass surgery for stable angina the Veterans Administration Coronary Artery Bypass Surgery
Cooperative Study N Engl J Med 1984 311 1333-9
180 Shook TL, Sun GW, Burstein S, Eisenhauer AC, Matthews RV Comparison of percuta­
neous transluminal coronary angioplasty outcome and hospital costs for low-volume and
high-volume operators Am J Cardiol 1996,77 331- 6
181 Kimmel SE, Berlin JA, Laskey WK The relationship between coronary angioplasty
procedure volume and major complications JAMA 1995,274 1137-42
182   Jollis JG, Peterson ED, Nelson CL, et al Relationship between physician and hospital
coronary angioplasty volume and outcome in elderly patients Circulation 1997,95 2485-91
183   Ellis SG, Weintraub W, Holmes D, Shaw R, Block PC, King SB Relation of operator
volume and experience to procedural outcome of percutaneous coronary revascularization at
hospitals with high interventional volumes Circulation 1997,95 2479 -84
184   Bashore TM, Bates ER, Berger PB, et al Cathetenzation laboratory standards a report
of the American College of Cardiology Task Force on Clinical Expert Consensus Docu­
ments (ACC/SCA&ICommittee to Develop an Expert Consensus Document on Cathe­
tenzation Laboratory Standards) J Am Coll Cardiol 2001,37 2170 -214
185  Pepme CJ, Babb JD, Bnnker JA, et al Guidelines for training in adult cardiovascular
medicine Core Cardiology Training Symposium (COCATS) Task Force 3 training in cardiac
cathetenzation and interventional cardiology J Am Coll Cardiol 1995,25 14 -6
186   Hirshfeld JW , Jr, Banas JS , Jr, Brundage BH, et al American College of Cardiology
training statement on recommendations for the structure of an optimal adult interventional
cardiology training program a report of the American College of Cardiology Task Force on
Clinical Expert Consensus Documents J Am Coll Cardiol 1999,34 2141-7
187   American Board of Internal Medicine Certification of Interventional Cardiology Phila­
delphia, PA American Board of Internal Medicine, 2000
188   Hamad N, Pichaid AD, Lyle HR, Lindsay J, Jr Results of percutaneous transluminal
coronary angioplasty by multiple, relatively low hequency operators   1986-1987 experi­
ence Am J Cardiol 1988,61   1229-31
189   Teirstein PS Credentiahng for coronary interventions practice makes perfect Circula­
tion 1997,95 2467-70
190   Hannan EL, Kilbuin HJ Bernard H, O'Donnell JF Lukacik G, Shields EP Coronary
artery bypass surgery the relationship between inhospital mortality rate and surgical volume
after controlling for clinical risk factors Med Care 1991,29 1094 -107
191   RyanTJ The critical question of procedure volume minimums lor coionary angioplasty
JAMA 1995 274 1169-70
192  Kastrati A, Neumann FJ, Schomig A Operator volume and outcome of patients under­going
coronary stent placement J Am Coll Cardiol 1998,32 970 -6
193  Ryan TJ, Antman EM, Brooks NH, et al ACC/AHA guidelines for the management of
patients with acute myocardial infarction a report of the American College of Cardiology/
American Heart Association Task Force on Practice Guidelines (Committee on Management
of Acute Myocardial Infarction) J Am Coll Cardiol 1999,34 890 -911
194  Scanlon PJ, Faxon DP, Audet A, et al ACC/AHA guidelines for coronary angiography a
report of the American College of Cardiology /American Heart Association Task Force on
Practice Guidelines (Committee on Coronary Angiography) J Am Coll Cardiol 1999, 33 1756 -824
195  Khnke WP, Hui W Percutaneous translummal coronary angioplasty without onsite
sur­gical facilities Am J Cardiol 1992,70 1520-5
196  Meier B, Urban P, Dorsa/ PA Favre J Surgical standby for coronary balloon angioplasty
JAMA 1992,268 741-5
197   Iniguez A, Macaya C, Hernandez R, et al   Comparison of results of percutaneous
translummal coronary angioplasty with and without selective requirement of surgical standby
Am J Cardiol 1992,69  1161-5
198  Sowton E, de Bono D, Gnbbm B, O'Keeffe B, et al Coronary angioplasty in the United
Kingdom Br Heart J 1991,66 325-31
199   Hubner PJ, Balcon R, Dyet J, Dymond DS, et al  Surgical cover for percutaneous translummal
coronary angioplasty Br Heart J 1992,68 339-1
200  Hasdai D, Berger PB, Bell MR, Rihal CS, Garratt KN, Holmes DR, Jr The changing
lace of coronary interventional practice   the Mayo Clinic experience  Arch Intern Med
1997,157 677-82
201   Altmann DB, Racz M, Battleman DS, et al  Reduction in angioplasty complications
after the introduction of coronary stents results from a consecutive series of 2242 patients
Am Heart J 1996,132 503-7
202   Stauffer JC, Eeckhout E, Vogt P, Kappenberger L, Goy JJ  Standby versus stent-by
during percutaneous translummal coronary angioplasty Am Heart J 1995,130 21-6
203   Berger PB, Stensrud PE, Daly RC  et al  Time to reperfusion and other procedural
characteristics of emergency coronary artery bypass surgery after unsuccessful
coronary angioplasty Am J Cardiol 1995,76 565-9
204   Beyersdorf F, Mitrev Z, Sarai K, et al   Changing patterns of patients undergoing emergency
surgical revasculanzation for acute coronary occlusion importance of myocar­dial
protection techniques J Thorac Cardiovasc Surg 1993,106 137-48
205  Nolleit G, Amend J, Detter C, Reichart В Coronary artery bypass grafting aftei failed
coronary angioplasty risk factors and longterm results Thorac Cardiovasc Surg 1995,43 35-9
206  Lazar HL, Faxon DP, Paone G, et al Changing profiles of failed coronary angioplasty
patients impact on surgical results Ann Thorac Surg 1992,53 269 -73
207  Talley JD, Weintraub WS, Roubin GS, ei al Failed elective percutaneous translummal
coronaiу angioplasty requiring coronaiy artery bypass surgery  inhospital and late clinical
outcome at 5 years Circulation 1990,82 1203-13
208  Eagle К A, Guyton RA, Davidoff R, et al Guidelines foi coronary artery bypass gialt
surgery a report of the American College of Cardiology/American Heart Association Task
Foice on Piactice Guidelines (Committee on Coronary Aiteiy Bypass Graft Surgeiy) J Am
Coll Cardiol 1999 34 1262-1347
209   Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
Gruppo Itahano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) Lancet
1986,1 397-402
210   Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187
cases of suspected acute myocardial infarction ISIS-2 ISIS-2 (Second International Study
of Infaict Survival) Collaborative Group Lancet 1988,2 349 -60
211  Weaver WD, Cerqueira M, Hallstrom AP, et al Prehospital-imtiated vs hospital-miti
ated thrombolytic therapy the Myocardial Infarction Triage and Intervention Trial JAMA
1993 270 1211-6
212   Stone GW, Brodie BR, Griffin JJ, et al Role of cardiac surgery in the hospital phase
management of patients treated with primary angioplasty for acute myocardial infarction
Am J Cardiol 2000,85 1292- 6
213   Vogel JH Changing trends for surgical standby in patients under-going percutaneous
translummal coronary angioplasty Am J Cardiol 1992,69 25F-32F
214   Wharton TP, Jr, McNamara NS, Fedele FA, Jacobs MI, Gladstone AR, Funk EJ Pri­
mary angioplasty for the treatment of acute myocardial infarction  experience at two
community hospitals without cardiac surgery J Am Coll Cardiol 1999,33 1257- 65
215   Weaver WD, Litwin PE, Martin JS Use of direct angioplasty for treatment of patients with
acute myocardial infarction in hospitals with and without on-site cardiac surgery the Myocardial
Infarction, Triage, and Intervention Project Investigators Circulation 1993,88 2067-75
216   Iannone LA, Anderson SM, Phillips SJ Coronary angioplasty for acute myocardial
infarction in a hospital without cardiac surgery Tex Heart Inst J 1993,20 99 -104
217   Brush JEJ, Thompson S, Ciuffo AA, et al Retrospective comparison of a strategy of
primary coronary angioplasty versus intravenous thrombolytic therapy for acute myocardial
infarction in a community hospital without cardiac surgical backup J Invas Cardiol 1996,8
91-8
218   Smyth DW, Richards AM, Elliott JM Direct angioplasty for myocardial infarction
one-year experience in a center with surgical backup 220 miles away J Invas Cardiol
1997,9 324-32
219   Weaver WD, Parsons LS, Every NR Primary coronary angioplasty in hospitals with
and without surgery backup J Invas Cardiol 1995,7 34F-9F
220   Meier В Surgical standby for percutaneous translummal coronary angioplasty In Topol
EJ, editor Textbook of Interventional Cardiology 3rd ed Phildelphia, PA WB Saunders
Company, 1999,466-74
221  Moosvi AR, Khaja F, Villanueva L, Gheorghiade M, Douthat L, Goldstein S  Early
revasculanzation improves survival in cardiogenic shock complicating acute myocardial
infarction J Am Coll Cardiol 1992 19 907-14
222  Hochman JS, Sleeper LA, Webb JG, et al Early revasculanzation m acute myocardial
infarction complicated by cardiogenic shock SHOCK Investigators Should We Emergently
Revasculanze Oc-cluded Coronanes for Cardiogenic Shock N Engl J Med 1999,341 625-34
223  Vogel JH Angioplasty in the patient with an evolving myocardial infarction with and
without surgical backup Chn Cardiol 1992,15 880-2
224  Lange RA, Hilhs LD Should thrombolysis or primary angioplasty be the treatment of
choice for acute myocardial infarction9 Thrombolysis  the preferred treatment N Engl J
Med 1996,3^5 1311-2, discussion 1316-7
225  Antman EM, Giughano RP, Gibson CM, et al Abciximab facilitates the rate and extent 
of thrombolysis results of the Thrombolysis In Myocaidial Infarction (TIMI) 14 trial The TIMI 14
Investigators Circulation 1999,99 2720-32
226  Magid DJ, Calonge BN, Rumsfeld JS, et al Relation between hospital primary angioplasty
volume and mortality for patients with acute MI treated with primary angioplasty vs throm
bolytic therapy JAMA 2000,284 3131-8
227  McGiath PD, Wennberg DE, Dickens JD, et al Relation between operatoi and hospital
volume and outcomes following percutaneous coronary interventions in the era of the coronary
stent JAMA 2000,284 3139 -44
228   Canto JG, Every NR, Magid DJ, et al The volume of primary angioplasty procedures
and survival after acute myocardial infarction National Registry of Myocardial Infarction 2 I
nvestigators N Engl J Med 2000,342 1573- 80
229  Cannon CP, Gibson CM, Lambrew CT, et al Relationship of symptom-onset-to-balloon
time and door-to-balloon time with mortality in patients undergoing angioplasty for acute
myocardial infarction JAMA 2000,283 2941-7
230  Caputo RP, Ho KK, Stoler RC, et al Effect of continuous quality improvement analysis
on the delivery of primary percutaneous transluminal coronary angioplasty for acute
myo­cardial infarction AmJCardiol 1997,79 1159-64
231   Loubeyre С, Мопсе MC, Berzin B, et al Emergency coronary artery bypass surgery
following coronary angioplasty and stenting results of a French multicenter registry Cathet
Cardiovasc Interv 1999,47 441-8
232   Vogt A, Bonzel T, Harmjanz D, et al PTCA registry of German community hospitals
Arbeitsgemeinschaft Leitender Kardiologis-cher Krankenhausarzte (ALKK) Study Group Eur
Heart J 1997,18  1110-4
233   Dellavalle A, Steffenino G, Ribichim F, Russo P, Uslenghi E  Elective coronary angioplasty
with and without surgical standby clinical and angiographic criteria for the se­lection of patients
Coron Artery Dis 1995,6 513-20
234  Richardson SG, Morton P, Murtagh JG, O'Keeffe DB, Murphy P, Scott ME Management
of acute coronary occlusion during percutaneous transluminal coronary angioplasty experi­ence
of complications in a hospital without on site facilities for cardiac surgery BMJ 1990,300 355-8
235  Reifart N, Preusler W, Schwai z F, et al A large center experience of coronary angioplasty
without on-site surgical standby In  Topol EJ, Serruys PW, editors  Current Review of
Interventional Cardiology 2nd ed Philadelphia, PA Current Medicine, 1995,296-303
236   Yusuf S, Wittes J, Probstfield J, Tyroler HA Analysis and interpretation of treatment
effects in subgroups of patients in randomized clinical trials JAMA 1991,266 93- 8
237  Loop FD, Whitlow PL "Beauty is in the eye      " Am J Cardiol 1992,70 1608 -9
238   Kent KM Interventional caidiology  1990s Am J Cardiol 1992,70  1607-8
239  Gnnes CL, Balestnm C, Westerhausen DR, et al A randomized trial of thrombolysis vs
transfei for primary PTCA in high risk AMI patients results of the AIR PAMI trial (abstr) J Am
Coll Cardiol 2000,35 Suppl 376A
240  Vainauskas E Survival, myocardial infarction, and employment status in a piospective
randomized study of coronary bypass surgery Circulation 1985,72 V90-101
241   Yusuf S, Zucker D, Pedi\77i P, ct al Effect of coionaiy aitery bypass graft suigery on
survival overview of 10 year lesults from landomised tuals by the Coronary Artery Bypass
Graft Surgery Tnahsts Collaboration [published erratum appears in Lancet 1994,344 1446]
Lancet 1994,344 563-70
242   Braunwald E, Jones RH, Mark DB, et al Diagnosing and managing unstable angina
Agency for Health Care Policy and Research Circulation 1994,90 613-22
243   Effects of tissue plasmmogen activator and a comparison of early invasive and
conservative strategies in unstable angina and non-Q-wave myocardial infarction results of
the TIMIIIIB Trial Thrombolysis in Myocardial Ischemia Circulation 1994,89 1545-56
244   Williams DO, Braunwald E, Thompson B, Sharaf BL, Buller CE, Knatterud GL Results
of pei cutaneous transluminal coronary angioplasty in unstable angina and non-Q-wave myo­
cardial infarction observations from the TIMI IIIB Trial Circulation 1996,94 2749 -55
245  Anderson HY, Cannon CP, Stone PH, et al One-year results of the Thrombolysis in
Myo­cardial Infarction (TIMI) IIIB clinical trial A randomized comparison of tissue-type plasmino-
gen activator versus placebo and early invasive versus early conservative strategies inunstable
angina and non-Q wave myocardial infarction J Am Coll Cardiol 1995,26 1643-50
246   Boden WE, O'Rourke RA, Crawford MH, et al Outcomes in patients with acute non-
Q-wave myocardial infarction randomly assigned to an invasive as compared with a
conservative management strategy Veterans Affairs Non-Q-Wave Infarction Strategies in
Hospital (VANQWISH) Trial Investigators [published erratum appears in N Engl J Med
1998,339 1091] NEnglJ Med 1998,338  1785-92
247   Invasive compared with non-invasive treatment in unstable coronary-artery disease
FRISC II prospective randomised multicentre study FRagmin and Fast Revasculansation
during Instability in Coronary artery disease Investigators Lancet 1999,354 708 -15
248   Long-term low-molecular-mass hepann in unstable coronary-artery disease FRISC II
prospective randomised multicentre study FRag-mm and Fast Revasculansation during
Instability in Coronary artery disease Investigators Lancet 1999,354 701-7
249   Cannon С TACTICS (Treat Angina with Aggrastat 1 Determine Cost of Therapy with
an Invasive or Conservative Strategy)-TIMI 18 (abstr) Chn Cardiol 2001,24 Suppl 86
250   Braunwald E, Antman EM, Beasley JW, et al ACC/AHA guidelines for the management
of patients with unstable angina and non-ST-segment elevation myocardial infarction a report
of the American College of Cardiology/American Heart Association Task Force on Practice
Guidelines (Committee on the Management of Patients With Unstable Angina) J Am Coll
Cardiol 2000,36 970-1062
251 Every NR, Parsons LS, Hlatky M, Martin JS, Weaver WD A comparison of throm-
bolytic therapy with primary coronary angioplasty for acute myocardial infarction Myocar­
dial Infarction Triage and Intervention Investigators N Engl J Med 1996,335 1253- 60
252   A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM)
mortality, morbidity, and infarct size at 21 days The ISAM Study Group N Engl J Med
1986,314 1465-71
253   Effect of intravenous APS AC on mortality after acute myocardial infarction prelimi­
nary report of a placebo-controlled clinical trial   AIMS Trial Study Group  Lancet
1988,1 545-9
254   An international randomized trial comparing four thrombolytic strategies for acute
myocardial infarction the GUSTO investigators N Engl J Med 1993,329 673- 82
255   Indications for fibnnolytic therapy in suspected acute myocardial infarction collaborative
oveiview ol early mortality and major morbidity results from all randomised trials of more
than 1000 patients Fibnnolytic Therapy Tnahsts' (FIT) Collaborative Group [pub-hshed
erratum appears in Lancet 1994,343 742] Lancet 1994,343 311-22
256  Wilcox RG, von der Lippe G, Olsson CG, Jensen G, Skene AM, Hampton, Jr Trial of
tissue plasminogen activator for mortality reduction in acute myocardial infarction Anglo-
Scandinavian Study of Early Thrombolysis (ASSET) Lancet 1988,2 525-30
257  O'Neill WW, Brodie BR, Ivanhoe R, et al  Primary coronary angioplasty for acute
myocardial infarction (the Primary Angioplasty Registry) Am J Cardiol 1994,73 627-34
258  O'Keete JH, Jr, Bailey WL, Rutherford BD, et al Primary angioplasty for acute myo-
cardial infarction in 1,000 consecutive patients Results in an unselected population and
high-risk groups Am J Cardiol 1993,72 107G-15G
259  Laster SB, O'Keefe JH, Jr, Gibbons RJ Incidence and importance of thrombolysis in
myocardial infarction grade 3 flow after primary percutaneous transluminal coronary angioplasty
for acute myocardial infarction Am J Cardiol 1996,78 623-26
260  Brodie BR, Gnnes CL, Ivanhoe R, et al Six-month clinical and angiographic follow-up after
direct angioplasty for acute myocardial infarction   final results from the Primary Angioplasty
Registry Circulation 1994,90 156-62
261   Brodie BR, Weintraub RA, Stuckey TD, et al Outcomes of direct coronary angioplasty
for acute myocardial infarction in candidatesand non-candidates for thrombolytic therapy
Am J Cardiol 1991,67 7-12
262  Stone GW, Brodie BR, Griffin JJ, et al Prospective, multicenter study of the safety and
feasibility of primary stenting in acute myocardial infarction m-hospital and 30-day results
of the PAMI stent pilot trial Primary Angioplasty in Myocardial Infarction Stent Pilot Trial I
nvestigators J Am Coll Cardiol 1998,31 23-30
263   Gnnes CL, Marsalese DL, Brodie B, et al Safety and costeffectiveness of early
dis­charge after primary angioplasty in low-risk patients with acute myocardial infarction
PAM-II Investigators   Primary Angioplasty in Myocardial Infarction   J Am Coll Cardiol
1998,31 967-72
264   Gnnes CL, Cox DA, Stone GW, et al  Coronary angioplasty with or without stent
implantation for acute myocardial infarction  Stent Primary Angioplasty in Myocardial
Infarction Study Group N Engl J Med 1999,341 1949 -56
265  Cox DA, Stone GW, Brodie B, etal Stent PAMI Are excellent outcomes acheived
only by experienced sites (abstr)? J Am Coll Cardiol 2000,35 Suppl A 363A
266  Gnnes CL, Browne KF, Marco J, et al A companson of immediate angioplasty with
thrombolytic therapy for acute myocardial infarction The Primary Angioplasty in Myocar­dial
Infarction Study Group N Engl J Med 1993,328 673-79
267  Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H A comparison
of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction
N Engl J Med 1993,328 680 -4
268  Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ Imme­diate
angioplasty compared with the administration of a thrombolytic agent followed by conservative
treatment for myocardial infarction The Mayo Coronary Care Unit and Catheter ization
Laboratory Groups N Engl J Med 1993,328 685-91
269  BlankenshipJC, MishkelGJ, Chambers CE, etal Ad hoc coronary intervention
Cathet Cardiovasc Interv 2000 49 130 -4
270   A clinical trial comparing primary coronary angioplasty with tissue plasminogen acti­
vator for acute myocardial infarction The Global Use of Strategies to Open Occluded Coronary
Arteries in Acute Coronary Syndromes (GUSTO lib) Angioplasty Substudy Investi-gators
[published erratum appears in N Engl J Med 1997,337 287] N Engl J Med 1997,336 1621—
8
271  Michels KB, Yusuf S Does PTCA in acute myocardial infarction affect mortality and 
reinfarction iates9 A quantitative overview (meta-analysis) of the randomized clinical trials
Circulation 1995,91 476-85
272  Weavei WD, Simes RJ, Betnu A, et al Comparison of primary coionary angioplasty
and intiavenous thrombolytic therapy for acute myocardial infarction a quantitative review
JAMA 1997,278 2093-8
273  Rodriguez A, Bernardi V, Fernandez M, et al In-hospital and late results of coronary
stents versus conventional balloon angioplasty in acute myocardial infarction (GRAMI trial)
Gianturco-Roubin in Acute Myocardial Infarction Am J Cardiol 1998,81 1286 -91
274   Antomucci D, Santoro GM, Bolognese L, Valenti R, Trapani M, Fazzini PF A clinical
trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty
for acute myocardial infarction results from the Florence Randomized Elective Stenting in
Acute Coronary Occlusions (FRESCO) trial J Am Coll Cardiol 1998,31 1234 -39
275   Maillard L, Hamon M, Khahfe K, et al  A comparison of systematic stenting and
conventional balloon angioplasty during primary percutaneous transluminal coronary
angioplasty for acute myocardial infarction STENTIM-2 Investigators J Am Coll Cardiol
2000,35   1729-36
276   Suryapranata H, van't Hof AW, Hoorntje JC, de Boer MJ, Zijlstra F Randomized
comparison of coronary stenting with balloon angioplasty in selected patients with acute
myocardial infarction Circulation 1998,97 2502-5
277   Saito S, Hosokawa G, Tanaka S, Nakamura S Primary stent implantation is superior to
balloon angioplasty in acute myocardial infarction final results of the primary angioplasty
versus stent implantation in acute myocardial infarction (PASTA) trial  PASTA Trial
Investigators Cathet Cardiovasc Interv 1999,48 262- 8
278   Schellei B, Hennen B, Sevenn-Kneib S, et al  Long-term follow-up of a randomized
study of primary stenting versus angioplasty in acute myocardial infarction  Am J Med
2001,110 1-6
279   Barbash GI, Roth A, Hod H, et al Randomized controlled tnal of late in-hospital an-
giography and angioplasty versus conservative management after treatment with recombinant
tissue-type plasminogen activator in acute myocardial infarction  Am J Cardiol 1990,66
538^5
280   SWIFT trial of delayed elective intervention v conservative treatment after thromboly-
sis with anistreplase in acute myocardial infarction SWIFT (Should We Intervene Follow­
ing Thrombolysis'?) Trial Study Group BMJ 1991,302 555-60
281   Comparison of invasive and conservative strategies after treatment with intravenous
tissue plasminogen activator in acute myocaidial infarction results ol the Thrombolysis Iin
Myocardial Infaiction (TIMI) phase II tnal   The TIMI Study Group   N Engl J Med
1989,320 618-27
282   Duber C, Jungbluth A, Rumpelt HJ, Erbel R Meyei J, Thoenes W Morphology oi the
coionaiy aitenes aftei combined thrombolysis and peicutaneous transluminal coionary
angioplasty for acute myocardial infarction Am J Cardiol 1986,58 698 -703
283   Rogers WJ, Bowlby LJ, Chandra NC, et al Treatment of myocardial infarction in the
United States (1990 to 1993)   observations from the National Registry of Myocardial
Infarction Circulation 1994,90 2103-14
284  Ellis SG, Debowey D, Bates ER, Topol EJ Treatment of recurrent ischemia after throm-
bolysis and successful reperfusion for acute myocardial infarction  effect on m-hospital
mortality and left ventricular function J Am Coll Cardiol 1991,17 752-7
285   Rogers WJ, Bairn DS, Gore JM, et al  Comparison of immediate invasive, delayed
invasive, and conservative strategies after tissue-type plasminogen activator Results of
the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial Circulation 1990,81 1457-76
286  Muller DW, Topol EJ, Ellis SG, et al Determinants of the need for early acute
interven­tion in patients treated conservatively after thiombolytic therapy for acute
myocardial infarction TAMI-5 Study Group J Am Coll Cardiol 1991,18 1594 -601
287  Trial of abciximab with and without low-dose reteplase for acute myocardial infarction
Strategies for Patency Enhancement in the Emergency Department (SPEED) Group
Circu­lation 2000,101  2788-94
288   Cahff RM Glycoprotein Hb/IIIa blockade and thrombolytics early lessons from the
SPEED and GUSTO IV trials Am Heart J 1999,138 S12-5
289  Cahff RM, Woodhef LH, Harrell FEJ, et al Selection of thrombolytic therapy for
indi­vidual patients  development of a clinical model  GUSTO-I Investigators  Am Heart
J 1997,133 630-9
290  Ross AM, Lundergan CF, Rohrbeck SC, et al Rescue angioplasty after failed
throm­bolysis technical and clinical outcomes in a large thrombolysis trial GUSTO-1
Angiographic Investigators Global Utilization of Streptokinase and Tissue Plasminogen
Activator for Oc­cluded Coronary Arteries J Am Coll Cardiol 1998,31 1511-7
291   Ellis SG, da Silva ER, Spaulding CM, Nobuyoshi M, Werner B, Talley JD Review
of immediate angioplasty after fibnnolytic therapy for acute myocardial infarction  insights
from the RESCUE I, RESCUE II, and other contemporary clinical experiences Am Heart
J 2000,139 1046-53
292  Ellis SG, da Silva ER, Heyndnckx G, et al Randomized comparison of rescue angioplasty
with conservative management of patients with early failure of thrombolysis for acute ante­rior
myocardial infarction Circulation 1994,90 2280 -84
293   Hochman JS, Boland J, Sleeper LA, et al Current spectrum of cardiogenic shock and
effect of early revasculanzation on mortality Results of an International Registry SHOCK
Registry Investigators Circulation 1995,91 873-81
294  Williams DO, Braunwald E, Knatterud G, et al One-year results of the Thrombolysis
In Myocardial Infarction investigation (TIMI) Phase II Trial Circulation 1992,85 533- 42
295  Ross AM, Coyne KS, Reiner JS, et al A randomized trial comparing primary angioplasty
with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute
myocardial infarction the PACT trial PACT investigators Plasminogen-activator Angio­plasty
Compatibility Trial J Am Coll Cardiol 1999,34 1954 -62
296  Jeremy RW, Hackworthy RA, Bautovich G, Hutton BF, Harris PJ Infarct artery perfu-sion
and changes in lelt ventricular volume inthe month after acute myocardial infarction J Am Coll
Cardiol 1987,9 989 -95
297   Kersschot IE, Brugada P, Ramentol M, et al Effects of early reperfusion in acute myo-
cardial infarction on arrhythmias induced by programmed stimulation  a prospective,
randomized study J Am Coll Cardiol 1986,7 1234 -42
298   Stadius ML, Davis K, Maynard C, Ritchie JL, Kennedy JW Risk stratification for 1-
year survival based on characteristics identified in the early hours of acute myocardial
infarction   the Western Washington Intracoronary Streptokinase Trial   Circulation
1986,74 703-11
299   Topol EJ, Califf RM, Vandormael M, et al A randomized tnal of late reperfusion therapy
for acute myocardial infarction Thrombolysis and Angioplasty in Myocardial Infarction-6
Study Group Circulation 1992,85 2090 -9
300   Dzavik V, Beanlands DS, Davies RF, et al Effects of late percutaneous transluminal
coronary angioplasty of an occluded infarctrelated coronary artery on left ventricular func­
tion in patients with a recent (,6 weeks) Q-wave acute myocardial infarction (Total Occlu­
sion Post-Myocardial Infarction Intervention Study [TOMIIS]-a pilot study) Am J Cardiol
1994,73 856-61
301        Cigarroa RG, Lange RA, Hillis LD Prognosis after acute myocardial infarction in patients
with and without residual anterograde coronary blood flow Am J Cardiol 1989,64 155- 60
302   Kim CB, Braunwald E Potential benefits of later reperfusion of infarcted myocardium
The open artery hypothesis Circulation 1993,88 2426 -36
303   Fortin DF, Califf RM Long-term survival from acute myocardial infarction salutary
effect of an open coronary vessel Am J Med 1990,88 9N-15N
304   Lamas GA, Pfeffer MA, Braunwald E Patency of the infarct-related coronary artery
and ventricular geometry Am J Cardiol 1991,68 41D-51D
305   Pizzetti G, Belotti G, Margonato A, et al Coronary recanahzation by elective angioplasty
prevents ventricular dilation after anterior myocardial infarction  J Am Coll Cardiol
1996,28 837-45
306   Boehrer JD, Glamann DB, Lange RA, et al Effect of coronary angioplasty on late poten­
tials one to two weeks after acute myocardial infarction Am J Cardiol 1992,70 1515-19
307   McCully RB, elZeky F, vanderZwaag R, et al Impact of patency of the left anterior
descending coronary artery on long-term survival Am J Cardiol 1995,76 250 -4
308   Welty FK, Mittleman MA, Lewis SM, et al A patient infarct-related artery is associated
with reduced long-term mortality after percutaneous transluminal coronary angioplasty for
postinfarction ischemia and an ejection fraction ,50% Circulation 1996,93 1496 -501
309   Nicod P, Gilpin EA, Dittnch H, et al Trends in use of coronary angiography in subacute
phase of myocardial infarction Circulation 1991,84 1004 -15
310   Aguirre FV, McMahon RP, Mueller H, et al Impact of age on clinical outcome and
postlytic management strategies in patients treated with intravenous thrombolytic therapy
results from the TIMIII Study TIMIII Investigators Circulation 1994,90 78 -86
311  Schulman SP, Achuff SC, Griffith LS, et al Prognostic cardiac cathetenzation variables
in survivors of acute myocardial infarction a five year prospective study J Am Coll Cardiol
1988,11 1164-72
312   Mueller HS, Cohen LS, Braunwald E, et al Predictors of early morbidity and mortality
after thrombolytic therapy of acute myocardial infarction analyses of patient subgroups in
the Thrombolysis In Myocardial Infarction (TIMI) trial, phase II  Circulation 1992,85
1254-64
313  Campeau L, Lesperance J, Hermann J, Corbara F, Grondin CM, Bourassa MG Loss
of the improvement of angina between 1 and 7 years after aortocoronary bypass surgery
correlations with changes in vein grafts and in coronary arteries Circulation 1979,60 1-5
314  Cameron A, Kemp HGJ, Shimomura S, et al Aortocoronary bypass surgery a 7-year
 follow up Circulation 1979,60 9-13
315  Johnson WD, Kayser KL, Pedraza PM Angina pectons and coronary bypass surgery patterns
of prevalence and recurrence in 3105 consecutive patients followed up to 11 years Am Heart
J 1984,108  1190-7
316  Cameron A, Davis KB, Rogers WJ Recurrence of angina after coronary artery bypass
surgery predictors and prognosis (CASS Registry) Coronary Artery Surgery Study J Am Coll
Cardiol 1995,26 895-9
317  Fnck MH, Valle M, Harjola PT Progression of coronary artery disease in randomized
medical and surgical patients over a 5-year angiographic follow-up   Am J Cardiol 1983,52 681-5
318  Palac RT, Hwang MH, Meadows WR, et al Progression of coronary artery disease in
medically and surgically treated patients 5 years after randomization   Circulation 1981,64 1117-21
319  Lawne GM, Lie JT, Morris GCJ, Beazley HL Vein graft patency and intimal prolifera­tion
after aortocoronary bypass  early and long-term angiopathologic correlations  Am J Cardiol
1976,38 856-62
320  Goldman SL, Copeland J, Montz T, et al Starting aspirin therapy after operation ef­fects
on early graft patency Department of Veterans Affairs Cooperative Study Group Cir­culation
1991,84 520-6
321   FitzGibbon GM, Burton JR, Leach AJ Coronary bypass graft fate angiographic grad­ing
of 1400 consecutive grafts early after operation and of 1132 after one year Circulation 1978,57
1070-^
322  Hamby RI, Aintabhan A, Handler M, et al Aortocoronary saphenous vein bypass grafts
long-term patency, morphology and blood flow in patients with patent grafts early after sur­gery
Circulation 1979,60 901-9
323  Bourassa MG, Enjalbert M, Campeau L, Lesperance J Progression of atherosclerosis in
coronary arteries and bypass grafts ten years later Am J Cardiol 1984,53 102C-7C
324  Bourassa MG, Fisher LD, Campeau L, Gillespie MJ, McConney M, Lesperance J Long-term fate of bypass grafts the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences Circulation 1985,72 V71-8
325  FitzGibbon GM, Leach AJ, Kafka HP, Keon WJ Coronary bypass graft fate long-term
angiographic study J Am Coll Cardiol 1991, 17 1075-80
326  ACC/AHA guidelines and indications for coronary artery bypass graft surgery a report of
 the American College of Cardiology/American Heart Association Task Force on Assess­ment
of Diagnos-tic and Therapeutic Cardiovascular Procedures (Subcommittee on Coronary Artery
Bypass Graft Surgery) J Am Coll Cardiol 1999,34  1262-1341
327   Hwang MH, Meadows WR, Palac RT, et al Progression of coronary artery disease in
medically and surgically tieated patients 5 years after randomization  J Am Coll Cardiol 1998,
16 1066-70
128 Weintraub WS Jones EL, Craver JM, Guyton RA Frequency of repeat coronary bypass or
coronary angioplasty alter coionary aitery bypass surgery using saphenous venous giafts Am
J Cardiol 1994, 73 103-12
329  Okies JE, Page US, Bigelow JC, Krause AH, Salomon NW The left internal mammary
artery the graft of choice Circulation 1984,70 1213-21
330  Tectoi AJ, Schmahl TM, Canino VR The internal mammary artery graft the best choice for bypass of the diseased left anterior descending coronary artery Circulation 1983,68 П214 -7
331 Loop FD, Lytle BW, Cosgrove DM, et al Reoperation for coronary atherosclerosis
changing practice in 2509 consecutive patients Ann Surg 1990,212 378 -85
332   Verheul HA, Mouhjn AC, Hondema S, Schouwink M, Dunning AJ Late results of 200
repeat coronary artery bypass operations Am J Cardiol 1991,67 24 -30
333   Hannan EL, Kilburn HJ, O'Donnell JF, Lukacik G, Shields EP Adult open heart sur­
gery in New York State  an analysis of risk factors and hospital mortality rates  JAMA
1990,264 2768-74
334   Lytle BW, Loop FD, Cosgrove DM, et al Fifteen hundred coronary reoperations results
and determinants of early and late survival J Thorac Cardiovasc Surg 1987,93 847-59
335   Cameron A, Kemp HG , Jr, Green GE Reoperation for coronary artery disease   10
years of clinical follow-up Circulation 1998,78 1158-62
336   Campeau L, Lesperance J, Bourassa MG Natural history of saphenous vein aortacoronary
bypass grafts Mod Concepts Cardiovasc Dis 1984,54 59 -63
337   Bourassa MG Fate of venous grafts the past, the present and the future J Am Coll
Cardiol 1991,17 1081-83
338   FitzGibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR Coronary
bypass graft fate and patient outcome angiographic follow-up of 5,065 grafts related to
survival and reoperationin 1,388 patients during 25 years J Am Coll Cardiol 1996,28 616
-26
339   Cox JL, Chiasson DA, Gotlieb Al Stranger in a strange land the pathogenesis of saphe­
nous vein graft stenosis with emphasis on structural and functional differences between veins
and arteries Prog Cardiovasc Dis 1991,34 45- 68
340   Kahn JK, Rutherford BD, McConahay DR, et al Early postoperative balloon coronary
angioplasty for failed coronary artery bypass grafting Am J Cardiol 1990,66 943- 46
341  Dimas AP, Arora RR, Whitlow PL, et al Percutaneous transluminal angioplasty involving
internal mammary artery grafts Am Heart J 1991,122 423-9
 342   Dorogy ME, Highfill WT, Davis RC  Use of angioplasty in the management of
complicated penoperative infarction following bypass surgery Cathet Cardiovasc Diagn
1993,29 279-82
343   Rentrop P, Blanke H, Karsch KR, Kostenng H, Oster H, Leitz H Recanahzation of
an acutely occluded aortocoronary bypass by intragraft fibnnolysis   Circulation
1980,62 1123-6
344   Holmes DR , Jr, Chesebro JH, Vhetstra RE, Orszulak ТА Streptokinase for vein graft
thiombosis a caveat Circulation 1981,63 729
345  Marx M, Annstrong WP, Wack JP, et al Shoit duration, high dose urokinase infusion
for lecanalization of occluded saphenous aoito coronary bypass grafts  Am J Roentgenol
1989,153 167-71
346   Hait/lei GO, Johnson WL, McConahay DR, et al Dissolution ol coronaiy artery by
pass giait thiombi by stieptokmase infusion Am J Caidiol 1981 47 493
347   Van Ommen VG, van den Bos AA, Pieper M, et al  Removal of thrombus from aortocoronary bypass grafts and coronary arteries using the 6Fr Hydrolyser Am J Cardiol 1997 79 1012-6
348  Douglas JS , Jr, Gruentzig AR, King SB III, et al Percutaneous transluminal coronary angioplasty in patients with prior coronary bypass surgery J Am Coll Cardioi 1983,2 745-54
349  Reeves F, Bonan R, Cote G, et al Long-term angiographic follow-up after angioplasty of venous coronary bypass grafts Am Heart J 1991,122 620 -7
350   Meester BJ, Samson M, Suryapranata H, et al Long-term follow-up after attempted angioplasty of saphenous vein grafts the Thorax-center experience 1981-1988 Eur Heart J 1991,12 648-53
351   de Feyter PJ, van Suylen RJ, de Jaegere PP, Topol EJ, Serruys PW Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts J Am Coll Cardioi 1993,21 1539 -49
352   Gruberg L, Hong MK, Mehran R, et al In-hospital and long-term results of stent de­ployment compared with balloon angioplasty for treatment of narrowing at the saphenous vein graft distal anastomosis site Am J Cardioi 1999,84 1381-4
353  Strauss BH, Natarajan MK, Batchelor WB, et al Early and late quantitative angiographic results of vein graft lesions treated by excimer laser with adjunctive balloon angioplasty Circulation 1995, 92 348 -56
354  Bittl JA, Sanborn ТА, Yardley DE, et al Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass graft lesions the Percutaneous Excimer Laser Coronary Angioplasty Registry Am J Cardioi 1994,74 144 -8
355  Stullman WS, Hilhard GK Unrecognized internal mammary artery stenosis treated by percutaneous angioplasty after coronary bypass surgery Am Heart J 1987,113 393-5
356  Vivekaphirat V, Yellen SF, Foschi A Percutaneous transluminal angioplasty of a steno­sis at the origin of the left internal mammary artery graft a case report Cathet Cardiovasc Diagn 1988,15 176-8
357  Sketch MHJ, Quigley PJ, Perez JA, et al Angiographic follow-up after internal mammary artery graft angioplasty Am J Cardioi 1992,70 401-3
358   Popma JJ, Cooke RH, Leon MB, et al Immediate procedural and long-term clinical results of internal mammary artery angioplasty Am J Cardioi 1992,69 1237-9
359  Isshiki T, Yamaguchi T, Tamura T, et al Percutaneous angioplasty of stenosed gastro-epiploic artery grafts J Am Coll Cardioi 1993,22 727-32
360  Breall JA, Grossman W, Stillman IE, Gianturco LE, Kim D Atherectomy of the subcla-vian artery for patients with symptomatic coronary subclavian steal syndrome J Am Coll Cardioi 1993,21   1564-7
361   Perrault LP, Carrier M, Hudon G, Lemarbre L, Hebert Y, Pelletier LC Transluminal angioplasty of the subclavian artery in patients with internal mammary grafts Ann Thorac Surg 1993,56 927-30
362   Tan KH, Henderson RA, Sulke N, Cooke RA, Karani S, Sowton E  Percutaneous transluminal coronary angioplasty in patients with prior coronary artery bypass grafting ten years' experience Cathet Cardiovasc Diagn 1994,32 11-7
363  Hong MK, Mehran R, Dangas G, et al Creatine kmase MB enzyme elevation following successful saphenous vem graft intervention is associated with late mortality Circulation 1999,100 2400-5
364   Abbo KM Doons M, Glazier S, et al Features and outcome of no-reflow atter percuta­
neous coronary intervention Am J Cardiol 1995 75 778 -82
365   Liu MW, Douglas JS , Jr, Lembo NJ, King SB III Angiographic predictors of a rise in
serum creatine kinase (distal embohzation) after balloon angioplasty of saphenous vein
coronary artery bypass grafts Am J Caidiol 1993,72 514   7
366   Meany ТВ, Leon MB, Kramer BL, et al Transluminal extiaction cathetei for the treat­
ment of diseased saphenous vein grafts a multicentei experience Cathet Cardiovasc Diagn
1995,34 112-20
367   Safian RD, Gnnes CL, May MA, et al Clinical and angiographic results of transluminal
extraction coionaiy atherectomy in saphenous vein bypass grafts Circulation 1994,89 302-
12
368   Doons M, Hoffmann M, Glazier S, et al Comparative results of transluminal extraction
coronary atherectomy in saphenous vein graft lesions with and without thrombus J Am Coll
Cardiol 1995,25  1700-5
369   Kaplan BM, Safian RD, Gnnes CL, et al Usefulness of adjunctive angioscopy and
extraction atherectomy before stent implantation in high-risk aortocoronary saphenous vein
grafts Am J Cardiol 1995, 76 822- 4
370   Hong MK, Popma JJ, Pichard AD, et al Clinical significance ol distal embohzation
after transluminal extraction atherectomy in diffusely diseased saphenous vein grafts Am
Heart J 1994,127 1496-503
371   Weyrens FJ, Mooney J, Lesser J, Mooney MR Intracoronary diltiazem tor microvascu-
lar spasm after interventional therapy Am J Cardiol 1995,75 849 -50
372   Мак KH, Challapalh R, Eisenberg MJ, Anderson KM, Califf RM, Topol EJ Effect of
platelet glycoprotein Ilb/IIIa receptor inhibition on distal embohzation during percutaneous
revasculanzation of aortocoronary saphenous vein grafts Am J Cardiol 1997,80 985- 8
373   Stephan WJ, Bates ER, Garratt KN, Hinohara T, Muller DW Directional atherectomy
of coronary and saphenous vein graft ostial stenoses Am J Cardiol 1995,75 1015- 8
374   Cowley MJ, Whitlow PL, Bairn DS, Hinohara T, Hall K, Simpson JB  Directional
coronary atherectomy of saphenous vein graft narrowings multicenter investigational expe­
rience Am J Cardiol 1993, 72 30E-4E
375   Abdelmeguid AE, Whitlow PL, Simpfendorfer C, et al Percutaneous revasculanzation
of ostial saphenous vein graft stenoses J Am Coll Cardiol 1995,26 955- 60
376   Rechavia E, Litvack F, Macko G, Eigler NL Stent implantation of saphenous vein graft
aorto ostial lesions in patients with unstable ischemic s\ndromes immediate angiographic
lesults and long-term clinical outcome J Am Coll Cardiol 1995,25 866 -70
377   Wong SC, Popma JJ, Pichaid AD, et al Comparison of clinical and angiographic out­
comes aftei saphenous vein graft angioplasty using coronary versus 'biliary' tubular slotted
stents Circulation 1995,91  339-50
378   Eeckhout E, Goy JJ, Stauffer JC, Vogt P, Kappenberger L Endoluminal stenting of
nan owed saphenous vein grafts   long-term clinical and angiographic follow-up  Cathet
Cardiovasc Diagn 1994,32 139-46
 379    Keane D, Buis B, Reifart N, et al  Clinical and angiographic outcome following
implantation of the new less shortening wallstent in aortocoronary vein grafts introduction
of a second generation stent in the clinical arena J Inteiv Cardiol 1994,7 557- 64
380    Fenton SH, Fischman DL Savage MP, et al Lone term angiographic and clinical out-
come after implantation of balloon-expandable stents in aortocoronary saphenous vein grafts Am JCardiol 1994,74 1187-91
381   Piana RN, Moscucci M, Cohen DJ, et al Palmaz-Schatz stentmg for treatment of focal vein graft stenosis immediate results and long-term outcome J Am Coll Cardiol 1994,23 1296 -304
382  Ellis SG, Brener SJ, DeLuca S, et al Late myocardial ischemic events after saphenous vein graft intervention   importance of initially "non-significant" vein graft lesions  Am J Cardiol 1997,79 1460-4
383  de Jaegere P, van Domburg RT, Feyter PJ, et al Long-term clinical outcome after stent implantation in saphenous vein grafts J Am Coll Cardiol 1996,28 89 -96
384   Hong MK, Mehran R, Dangas G, et al  Comparison of time course of targe lesion revasculanzation following successful saphenous vein graft angioplasty versus successful native coronary angioplasty Am J Cardiol 2000,85 256 -8
385   Kahn JK, Rutherford BD, McConahay DR, et al Initial and long-term outcome of 83 patients after balloon angioplasty of totally occluded bypass grafts  J Am Coll Cardiol 1994,23 1038-42
386  Hartmann JR, McKeever LS, Stamato NJ, et al Recanahzation of chronically occluded aortocoronary saphenous vein bypass grafts by extended infusion of urokinase initial results and short-term clinical follow-up J Am Coll Cardiol 1991,18 1517-23
387   Hartmann JR, McKeever LS, O'Neill WW, et al  Recanahzation of chronically oc­cluded aortocoronary saphenous vein bypass grafts with long-term, low dose direct infusion of urokinase (ROBUST) a serial trial J Am Coll Cardiol 1996,27 60 -6
388  Denardo SJ, Morris NB, Rocha-Singh KJ, Curtis GP, Rubenson DS, Teirstein PS Safety and efficacy of extended urokinase infusion plus stent deployment for treatment of obstructed, older saphenous vein grafts Am J Cardiol 1995,76 776 -80
389  McKeever LS, Hartmann JR, Bufahno VJ, et al Acute myocardial infarction complicating recanahzation of aortocoronary bypass grafts with urokinase therapy Am J Cardiol 1989,64 683-5
390  Blankenship JC, Modesto ТА, Madigan NP Acute myocardial infarction complicating urokinase infusion for total saphenous vein graft occlusion  Cathet Cardiovasc Diagn 1993,28 39-43
391   Gurley JC, MacPhail BS Acute myocardial infarction due to thrombolytic reperfusion of chronically occluded saphenous vein coronary bypass grafts Am J Cardiol 1991,68 274 -5
392   Margohs JR, Mogensen L, Mehta S, Chen CY, Krauthamer D Diffuse embohzation following percutaneous transluminal coronary angioplasty of occluded vein grafts the blush phenomenon Clin Cardiol 1991,14 489-93
393   Taylor MA, Santoian EC, Aji J, Eldredge WJ, Cha SD, Dennis CA  Intracerebral hemorrhage complicating urokinase infusion into an occluded aortocoronary bypass graft Cathet Cardiovasc Diagn 1994, 31 206 -10
394  Bedotto JB, Rutherford BD, Hartzler GO Intramyocardial hemorrhage due to prolonged intracoronary infusion of urokinase into a totally occluded saphenous vein bypass graft Cathet Cardiovasc Diagn 1992,25 52- 6
395   Chapekis AT, George BS, Candela RJ  Rapid thrombus dissolution by continuous infusion of urokinase through an intiacoronary perfusion wne prior to and following PTC A results in native coronanes and patent saphenous vein grafts  Cathet Cardiovasc Diagn 1991 23 89-92
396   Sabn MN, Johnson D, Warner M, Cowley MJ Intracoronary thrombolysis followed by
directional atherectomy a combined approach for thrombotic vein graft lesions considered
unsuitable for angioplasty Cathet Cardiovasc Diagn 1992,26 15-8
397   Whisenant BK, Baim DS, Kuntz RE, Garcia LA, Ramee SR, Carrozza JP Rheolytic
Thrombectomy with the Possis AngioJet Technical Considerations and Initial Clinical Ex­
perience J Invas Cardiol 1999,11 421-6
398   El Gamal M, Bonnier H, Michels R, Heijman J, Stassen E Percutaneous transluminal
angioplasty of stenosed aortocoronary bypass grafts Br Heart J 1984,52 617-20
399    Block PC, Cowley MJ, Kaltenbach M, Kent KM, Simpson J   Percutaneous
angioplasty of stenoses of bypass grafts or of bypass graft anastomotic sites Am J Cardiol
1984,53 666-8
400   Dorros G, Johnson WD, Tector AJ, Schmahl TM, Kalush SL, Janke L Percutaneous
transluminal coronary angioplasty in patients with prior coronary artery bypass grafting J
Thorac Cardiovasc Surg 1984,87 17-26
401        Corbelh J, Franco I, Hollman J, Simpfendorfer C, Galan К Percutaneous transluminal
coronary angioplasty after previous coronary artery bypass surgery  Am J Cardiol
1985,56 398-403
402   Reeder GS, Bresnahan JF, Holmes DR , Jr, et al Angioplasty for aortocoronary bypass
graft stenosis Mayo Chn Proc 1986,61 14-9
403   Cote G, Myler RK, Stertzer SH, et al Percutaneous transluminal angioplasty of stenotic
coronary artery bypass grafts 5 years' experience J Am Coll Cardiol 1987,9 8-17
404   Ernst SM, van der Feltz ТА, Ascoop CA, et al Percutaneous transluminal coronary
angioplasty in patients with prior coronary artery bypass grafting J Thorac Cardiovasc Surg
1987,93 268-75
405   Pinkerton CA, Slack JD, Orr CM, VanTassel JW, Smith ML Percutaneous transluminal
angioplasty in patients with prior myocardial revasculanzation surgery Am J Cardiol
1988,61 15G-22G
406   Dorros G, Lewin RF, Mathiak LM, et al Percutaneous transluminal coronary angioplasty
in patients with two or more previous coronary artery bypass grafting operations Am J Cardiol
1988,61 1243-7
407   Reed DC, Beller GA, Nygaard TW, Tedesco C, Watson DD, Burwell LR The clinical
efficacy and scintigraphic evaluation of post-coronary bypass patients undergoing percuta­
neous transluminal coronary angioplasty for recurrent angina pectons Am Heart J 1989,
117 60-71
408   Cooper I, Ineson N, Demirtas E, Coltart J, Jenkins S, Webb-Peploe M  Role of
angioplasty in patients with previous coronary artery bypass surgery Cathet Cardiovasc
Diagn 1989,16 81-6
409  Platko WP, Hollman J, Whitlow PL, Franco I Percutaneous transluminal angioplasty of
saphenous vein graft stenosis long-term follow up J Am Coll Cardiol 1989,14 1645-50
410   Kussmaul WG  Percutaneous angioplasty of coronary bypass grafts   an emerging
consensus Cathet Cardiovasc Diagn 1988,15 1-4
411   Lytle ВW, McElroy D McCarthy P, et al Influence of arterial coronary bypass grafts on
the mortality in coronaiy reoperations J Thoiac Cardiovasc Surg 1994 107 675- 82
412  Mishra YK, Mehta Y, Juneja R, Kashwal RR, Mittal S, Trehan N Mammary-coronary artery anastomosis without cardiopulmonary bypass through a mimthoracotomy Ann Thorac Surg 1997,63 S114-S8
413  Allen KB, Matheny RG, Robison RJ, Heimansohn DA, Shaar CJ Minimally invasive veisus comentional reoperative coronary artery bypass Ann Thorac Surg 1997,64 616 -22
414   Calafiore AM, Giammarco GD, Teodon G, et al Left antenor descending coronary aitery grafting via left anterior small thoracotomy without cardiopulmonary bypass Ann Thorac Surg 1996,61   1658-63
415  Boonstra PW, Grandjean JG, Manani MA Reoperative coronary bypass grafting without cardiopulmonary bypass through a small thoracotomy Ann Thorac Surg 1997,63 405-7
416  Grossi EA, Groh MA, Lefrak EA, et al Results of a prospective multicenter study on port-access coronary bypass grafting Ann Thorac Surg 1999,68 1475-7
417   Cohen HA, Zenati M  Integrated Coronary Revasculanzation  J Invasive Cardiol 1999,11 184-91
418  Angelmi GD, Wilde P, Salerno ТА, Bosco G, Calafiore AM Integrated left small thora­cotomy and angioplasty foi multivessel coronary artery revasculansation [letter]  Lancet 1996,347 757-8
419   Cavender JB, Rogers WJ, Fisher LD, Gersh BJ, Coggin CJ, Myers WO Eftects of smoking on survival and morbidity in patients randomized to medical oi surgical therapy in the Coronary Artery Surgery Study (CASS)  10-year follow-up CASS Investigators J Am Coll Cardiol 1992,20 287-94
420  Voors AA, van Brussel BL, Plokker HW, et al Smoking and cardiac events after venous coronary bypass surgery a 15-year follow-up study Circulation 1996,93 42-7
421   Sacks FM, Pfeffer MA, Moye LA, et al The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels  Cholesterol and Recurrent Events Trial investiga-tors N Engl J Med 1996,335 1001-9
422  The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts The Post Coronary Artery Bypass Graft Trial Investigators [published erratum appears in N Engl J Med 1997,337 1859] N Engl J Med 1997,336 153- 62
423   Colombo A, Hall P, Nakamura S, et al Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance Circulation 1995,91 1676 -88
424   Kern MJ, Dupouy P, Drury JH, et al  Role of coionary artery lumen enlargement in improving coronary blood flow after balloon angioplasty and stenting a combined intravas­cular ultrasound Doppler flow and imaging study J Am Coll Cardiol 1997,29 1520 -7
425  TobisJ, Colombo A IVUS and coronary stenting Cathet Cardiovasc Diagn 1996,39 346
426   Yock PG, Fitzgerald PJ, Linker DT, Angelsen BA Intravascular ultrasound guidance for catheter-based coronary interventions J Am Coll Cardiol 1991,17 39B-45B
427   Mudra H, Klauss V, Blasini R, et al   Ultrasound guidance of Palmaz-Schatz intracoronary stenting with a combined intravascular ultrasound balloon cathetei Circula­tion 1994,90 1252-61
428   Nakamura S, Colombo A, Gaghone A, et al  Intracoronary ultra-sound observations duiing stent implantation Circulation 1994,89 2026-34
429  Kami Ion GJ Monce MC, Benveniste E, et al Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy 30-day clinical outcome of the French Multicenter Registry Circulation 1996,94 1519-27
430   Moussa I, Moses J, Di Mario C, et al Does the specific intravascular ultrasound criterion
used to optimize stent expansion have an impact on the probability of stent restenosis7 Am J
Cardiol 1999,83 1012-7
431  Fitzgerald PJ, Oshima A, Hayase M, et al Final results of the Can Routine Ultrasound
Influence Stent Expansion (CRUISE) study Circulation 2000,102 523-30
432   Donohue TJ, Kern MJ, Aguirre FV, et al Assessing the hemodynamic significance of
coronary artery stenoses  analysis of translesional pressure-flow velocity relations in pa
tients J Am Coll Cardiol 1993,22 449 -58
433   Miller DD, Donohue TJ, Youms LT, et al  Correlation of pharmacological 99mTc-
sestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients
with angiographically intermediate coronary artery stenoses Circulation 1994,89 2150 -60
434  Heller LI, Cates C, Popma J, et al Intracoronary Doppler assessment of moderate coronary
artery disease comparison with 201T1 imaging and coronary angiography FACTS Study
Group Circulation 1997, 96 484 -90
435   Baumgart D, Haude M, Goerge G, et al Improved assessment of coronary stenosis
severity using the relative flow velocity reserve Circulation 1998,98 40 -6
436   Pijls NH, Van Gelder B, Van der VoortP,etal Fractional flow reserve a useful index to
evaluate the influence of an epicardial coronary stenosis on myocardial blood flow Circula­
tion 1995,92 3183-93
437   Kern MJ, Donohue TJ, Aguirre FV, et al Clinical outcome of deferring angioplasty in
patients with normal translesional pressure-flow velocity measurements J Am Coll Cardiol
1995,25 178-187
438   Pijls NH, De Bruyne B, Peels K, et al Measurement of fractional flow reserve to assess
the functional seventy of coronary-artery stenoses N Engl J Med 1996,334 1703- 8
439   Bech GJ, Pijls NH, De Bruyne B, et al Usefulness of Fractional Flow Reserve to Pre­
dict Clinical Outcome After Balloon Angioplasty Circulation 1999,99 883- 8
440   Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL Experimental basis of
determining maximum coronary, myocardial, and collateral blood flow by pressure
measurements for assessing functional stenosis severity before and after percutaneous
transluminal coronary angioplasty Circulation 1993,87 1354-67
441         De Bruyne B, Bartunek J, Sys SU, Heyndnckx GR Relation between myocardial frac
tional flow reserve calculated from coronary pressure measurements and exercise-induced
myocardial ischemia Circulation 1995,92 39 -46
442   Serruys PW, Di Мало С, Piek J, et al Prognostic value of intracoronary flow velocity
and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon
angioplasty the DEBATE Study (Doppler End points Balloon Angioplasty Trial Euiope)
Circulation 1997,96 3369 -77
443   Bairn DS, Hinohara T, Holmes D, et al Results of directional coronary atherectomy
during multicenter preapproval testing   the U S   Directional Coronary Atherectomy
Investigator Group Am J Cardiol 1993,72 6E-1 IE
444   Warth DC, Leon MB, O'Neill W, Zacca N, Polissar NL, Buchbinder M  Rotational
atherectomy multicenter registry   acute results, complications and 6-month angiographic
follow up in 709 patients J Am Coll Cardiol 1994,24 641- 8
445  Popma JJ, Brogan WC, III, Pichard AD, et al Rotational coronary atherectomy of ostial stenoses Am J Cardiol 1993,71 436-8
446  Jain SP, Liu MW, Dean LS, et al Comparison of balloon angioplasty versus debulking devices versus stenting in right coronary ostial lesions Am J Cardiol 1997,79 1334 -8
447  Ahmed WH, al-Anazi MM, Bittl JA Excimer laser-facilitated angioplasty for undilatable coronary narrowings Am J Cardiol 1996,78 1045- 6
448   Safian RD, Freed M, Reddy V, et al  Do excimer laser angioplasty and rotational atherectomy facilitate balloon angioplasty7 Implications for lesion-specific coronary inter­vention J Am Coll Cardiol 1996,27 552-9
449   Appelman YE, Koolen JJ, Piek JJ, et al  Excimer laser angioplasty versus balloon angioplasty in functional and total coronary occlusions Am J Cardiol 1996,78 757- 62
450  Reifart N, Vandormael M, Krajcar M, et al Randomized comparison of angioplasty of complex coronary lesions at a single center Excimer Laser, Rotational Atherectomy, and Balloon Angioplasty Comparison (ERBAC) Study Circulation 1997,96 91-8
451   Appelman YE, Piek JJ, Stnkwerda S, et al Randomised tnal of excimer laser angioplasty versus balloon angioplasty for treatment of obstructive coronary artery disease  Lancet 1996,347 79-84
452   Bittl JA   Excimer laser angioplasty   focus on total occlusions   Am J Cardiol 1996,78 823-4
453  Lembo NJ, Black AJ, Roubin GS, et al Effect of pretreatment with aspirin versus aspi­rin plus dipyndamole on frequency and type of acute complications of percutaneous transluminal coronary angio-plasty Am J Cardiol 1990,65 422- 6
454  Timmermans C, Vrohx M, Vanhaecke J, et al Ridogrel in the setting of percutaneous transluminal coronary angioplasty Am J Cardiol 1991,68 463- 6
455   Knudtson ML, Fhntoft VF, Roth DL, Hansen JL, Duff HJ  Effect of short-term prostacychn administration on restenosis after percutaneous transluminal coronary angioplasty J Am Coll Cardiol 1990,15 691-7
456   Gregonni L, Marco J, Fajadet J, et al  Ticlopidine and aspinn pretreatment reduces coagulation and platelet activation during coronary dilation procedures J Am Coll Cardiol 1997,29 13-20
457  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) CAPRIE Steering Committee Lancet 1996,348 1329-39
458  Hearn JA, King SB, III, Douglas JSJ, Carhn SF, Lembo NJ, Ghazzal ZM Clinical and angiographic outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty initial results with a balloon-expandable, stainless steel design Circulation 1993,88 2086 -96
459   Goldberg SL, Colombo A, Nakamura S, Almagor Y, Maiello L, Tobis JM Benefit of intracoronary ultrasound in the deployment of Palmaz- Schatz stents J Am Coll Cardiol 1994,24 996-1003
460  Hall P, Colombo A, Almagor Y, et al Preliminary experience with intravascular ultra­sound guided Palmaz-Schatz coronary stenting   the acute and short-term results on a consecutive series of patients J Interv Cardiol 1994,7 141-59
461   Schomig A, Neumann FJ, Kastrati A, et al A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-aitery stents  N Engl J Med 1996 334 1084-9
462   Urban P, Macaya C, Rupprecht HJ, et al Randomized evaluation of anticoagulation
versus antiplatelet therapy aftei coronaiy stent implantation in high risk patients   the
multicentei aspirin and ticlopidine after intracoronary stenting (MATTIS) Circulation 1998,98
2126-32
463   Steinhubl SR, Lauer MS, Mukerjee DP, Mohterno DJ, Ellis SG, Topol EJ The duration
of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-
related non Q wave myocardial infarctions J Am Coll Cardiol 1998,32 1366 -70
464   Hass WK, Easton JD, Adams HPJ, et al A randomized trial comparing ticlopidine
hydrochlonde with aspirin for the prevention of stroke in high risk patients  Ticlopidine
Aspirin Stroke Study Group N Engl J Med 1989,321 501-7
465   Rodriguez JN, Fernandez-Jurado A, Dieguez JC, Amian A, Prados D Ticlopidine and
severe aplastic anemia [letter] Am J Hematol 1994,47 332
466   Bellavance A Efficacy of ticlopidine and aspirin for prevention of reversible cere-
brovascular ischemic events the Ticlopidine Aspirin Stroke Study Stroke 1993,24 1452-7
467   Page Y, Tardy B, Zem F, Comtet C, Terrana R, Bertrand JC Thrombotic thrombocy-
topenic purpura related to ticlopidine Lancet 1991,337 774 -6
468   Kupfer Y, Tessler S Ticlopidine and thrombotic thrombocytopenic purpura [letter] N
Engl J Med 1997,337 1245
469   Bennett CL, Weinberg PD, Rozenberg-Ben-Dror K, Yarnold PR, Kwaan HC, Green D
Thrombotic thrombocytopenic purpura associated with ticlopidine  a review of 60 cases
Ann Intern Med 1998,128 541-4
470   Szto GYT, Linnemeier TJ, Lewis SJ, et al Safety of 10 days of ticlopidine after coronary
stenting a randomized comparison with 30 days Strategic ALternatives with Ticlopidine in
Stenting Study (SALTS) (abstr) J Am Coll Cardiol 1998,31 Suppl 352A
471         Berger PB, Bell MR, Hasdai D, Grill DE, Melby S, Holmes DR , Jr Safety and efficacy
of ticlopidine for only 2 weeks after successful intracoronary stent placement Circulation
1999,99 248-53
472   Moussa I, Oetgen M, Roubin G, et al Effectiveness of clopidogrel and aspirin versus
ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation Cir­
culation 1999,99 2364-6
473   Berger PB, Bell MR, Rihal CS, et al Clopidogrel versus ticlopidine after intracoronary
stent placement J Am Coll Cardiol 1999,34 1891-4
474   Mishkel GJ, Aguirre FV, Ligon RW, Rocha-Singh KJ, Lucore CL Clopidogrel as ad-
junctive antiplatelet therapy during coronary stenting J Am Coll Cardiol 1999,34 1884 -90
475   Muller C, Buttner HJ, Petersen J, Roskamm H A randomized comparison of clopidogrel
and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents Cir­
culation 2000,101  590-3
476   Gasperetti CM, Gomas SL, Gimple LW, Powers ER Platelet activation during coronary
angioplasty in humans Circulation 1993, 88 2728 -34
477   Anderson HV, Kirkeeide RL, Krishnaswami A, et al Cyclic flow variations after coronary
angioplasty in humans clinical and angiographic characteristics and elimination with 7E3
monoclonal antiplatelet antibody J Am Coll Cardiol 1994,23 1031-7
478   Use of a monoclonal antibody directed against the platelet glycoprotein Ilb/IIIa receptor
in high-risk coronary angioplasty the EPIC Investigation N Engl J Med 1994 330 956 -61
479   Topol EJ Ferguson JJ, Weisman HF, et al  Long term protection fiom myocardial is
chemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention EPIC Investigator Group Evaluation of Platelet Ilb/IIIa Inhibition for Preven­tion of Ischemic Complication JAMA 1997,278 479 -84
480  Brener SJ, Barr LA, Burchenal JE, et al Randomized, placebo-controlled trial of plate­let glycoprotein Ilb/IIIa blockade with primary angioplasty for acute myocardial infarction ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators Circulation 1998,98 734-41
481   Kereiakes DJ, Lincoff AM, Miller DP, et al Abciximab therapy and unplanned coronary stent deployment favorable effects on stent use, clinical outcomes, and bleeding complications EPILOG Trial Investigators Circulation 1998,97 857-64
482  Topol EJ, Mark DB, Lincoff AM, et al Outcomes at 1 year and economic implications of platelet glycoprotein Ilb/IIIa blockade in patients undergoing coronary stenting results from a multicentre randomised trial EPISTENT Investigators Evaluation of Platelet ПЬЯИа Inhibitor for Stenting Lancet 1999,354 2019 -24
483   Heeschen C, Hamm CW, Bruemmer J, Simoons ML Predictive value of C-reactive protein and tropomn T in patients with unstable angina a comparative analysis CAPTURE Investigators Chimenc c7E3 AntiPlatelet Therapy in Unstable angina REfractory to stan­dard treatment trial J Am Coll Cardiol 2000,35 1535- 42
484   Hamm CW, Heeschen C, Goldmann B, et al  Benefit of abciximab in patients with refractory unstable angina in relation to serum tropomn T levels c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators [published erratum appears in N Engl J Med 1999,34 548] N Engl J Med 1999,340 1623-9
485  Madan M, Kereiakes DJ, Hermiller JB, et al Efficacy of abciximab readministration in coronary intervention Am J Cardiol 2000,85 435^10
486  Randomised placebo-controlled trial of abciximab before and dunng coronary interven­tion in refractory unstable angina the CAPTURE Study[pubhshed erratum appears in Lancet 1997 350 744] Lancet 1997,349 1429 -35
487  Bhatt DL, Lincoff AM, Kereiakes DJ, et al Reduction in the need for unplanned stenting with the use of platelet glycoprotein ПЬЯИа blockade in percutaneous coronary intervention Am J Cardiol 1998,82 1105- 6, A6
488   Tcheng JE, Kereiakes DJ, Braden GA, et al  Safety of abciximab retreatment  final clinical report of the ReoPro readministration registry (R3) Circulation 1998,98 Suppl 1-17
489  Randomised placebo-controlled trial of effect of eptifibatide on complications of percu­taneous coronary intervention IMPACT-II Integnlin to Minimise Platelet Aggregation and Coronary Thrombosis II Lancet 1997,349 1422-8
490  Inhibition of platelet glycoprotein Ilb/IIIa with eptifibatide in patients with acute coronary syndromes  The PURSUIT Trial Investigators  Platelet Glycoprotein Ilb/IIIa in Unstable Angina Receptor Suppression Using Integnlin Therapy N Engl J Med 1998,339 436 -43
491   Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT) a randomised, placebo controlled trial Lancet 2000,356 2037- 44
492  O'shea JC, Madan M, Cantor WJ, et al Design and methodology of the ESPRIT trial evaluating a novel dosing regimen eptifibatide in percutaneous coronary intervention Am Heart J 2000,140 834-9493   Peerhnck K, De Lepeleire I, Goldberg M, et al MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein Ilb/IIIa antagonist, is active in man   Circulation 1993 88 1512-7
494  Effects of platelet glycoprotein Ilb/IIIa blockade with tirofiban on adverse cardiac events
in patients with unstable angina or acute myocardial infarction undergoing coronary
angioplasty the RESTORE Investigators Randomized Efficacy Study of Tirofiban for Out­
comes and Restenosis Си culation 1997,96 1445-53
495   Barr E, Snapmn SM, Sax FL, Theroux P Improved long-term clinical outcomes in
unstable angina patients undergoing coronary angioplasty following therapy with tirofiban
and hepann (absti) J Am Coll Cardiol 1998,31 Suppl 55A
496   Bhatt DL, Marso SP, Lincoff AM, Wolski KE, Ellis SG, Topol EJ Abciximab reduces
mortality in diabetics following percutaneous coronary intervention J Am Coll Cardiol
2000,35 922- 8
497   Topol EJ, Byzova TV, Plow EF Platelet GP Ilb/IIIa blockers Lancet 1999,353 227-31
498   Topol EJ, Bonan R, Jewitt D, et al Use of a direct antithrombin, hirulog, in place of
hepann during coronary angioplasty Circulation 1993,87 1622-9
499   Grayburn PA, Willard JE, Bnckner ME, Eichhorn EJ In vivo thrombus formation on a
guidewire during intravascular ultrasound imaging evidence for inadequate hepanmzation
Cathet Cardiovasc Diagn 1991,23 141-3
500   Dougherty KG, Gaos CM, Bush HS, Leachman DR, Ferguson JJ Activated clotting
times and activated partial thromboplastin times in patients undergoing coronary angioplasty
who receive bolus doses of hepann Cathet Cardiovasc Diagn 1992,26 260 -3
501         Bowers J, Ferguson JJ, III The use of activated clotting times to monitor heparm therapy
during and after mterventional procedures Chn Cardiol 1994,17 357-361
502   Ferguson JJ All ACTs are not created equal (editorial) Texas Heart Inst J 1992,19 1-3
503   Bull BS, Korpman RA, Huse WM, Bnggs BD Hepann therapy during extracorporeal
circulation  I  problems inherent in existing heparin protocols J Thorac Cardiovasc Surg
1975,69 674-84
504   Young JA, Kisker CT, Doty DB  Adequate anticoagulation during cardiopulmonary
bypass determined by activated clotting time and the appearance of fibrin monomer Ann
Thorac Surg 1978,26 231-40
505   Schiele F, Vuillemenot A, Kramarz P, et al Use of recombinant hirudin as antithrombotic
treatment in patients with hepann-induced thrombocytopema Am J Hematol 1995,50 20 -5
506   Brack MJ, More RS, Hubner PJ, Gershhck AH The effect of low dose nitroglycenn on
plasma heparin concentrations and activated partial thromboplastin times Blood Coagul Fi-
bnnolysis 1993,4   183-6
507   Habbab MA, Haft JI Heparin resistance induced by intravenous nitroglycenn a word
of caution when both drugs are used concomitantly Arch Intern Med 1987,147 857- 60
508   Ferguson JJ, Dougherty KG, Gaos CM, Bush HS, Marsh КС, Leachman DR Relation
between procedural activated coagulation time and outcome after percutaneous transluminal
coronary angioplasty J Am Coll Cardiol 1994,23 1061-5
509   Nanns CR, Hillegass WBJ, Nelson CL, et al Relation between activated clotting time
during angioplasty and abrupt closure Circulation 1996,93 667-71
510   Fnerson JH, Dimas AP, Simpfendorfer CC, Pearce G, Miller M, Pianco I Is aggressive
hepanni/ation necessary lor elective PTCA^ Cathet Cardiovasc Diagn 1993,28 279 -82
511         Popma JJ, Satler LF, Pichard AD, et al Vascular complications after balloon and new
device angioplasty Circulation 1993,88 1569-78
512   Koch KT, Piek JJ, de Winter RJ, et al Safety of low dose hepann m elective coionary
angioplasty Heart 1997,77 517-22
513  Boccara A, Benamer H Juliard JM, et al A randomized trial of a fixed high dose versus a weight adjusted low dose of intravenous hepann during coronary angioplasty Eur Heart J 199718 631-5
514   Friedman HZ, Cragg DR, Glazier SM, et al  Randomized prospective evaluation of prolonged versus abbreviated intravenous hepann therapy after coronary angioplasty J Am CollCardiol 1994,24  1214-9
515  Fail PS, Maniet AR, Banka VS Subcutaneous hepann in postangioplasty management comparative trial with intravenous hepann Am Heart J 1993,126 1059 -67
516   Kong DF  Califf RM   Post-procedure hepann   boon or burden7 Am Heart J 1998,136 183-5
517  Garachemam AR, Kaufmann U, Fleisch M, Meier В Prolonged hepann aftei uncomph cated coronary interventions a prospective, randomized trial Am Heart J 1998,136 352- 6
518   Goodman SG, Cohen M, Bigonzi F, et al Randomized trial of low molecular weight hcpann (enoxapann) versus unfractionated hepann for unstable coronary artery disease one-year results of the ES SENCE Study Efficacy and Safety of Subcutaneous Enoxapann in Non Q Wave Coronary Events J Am Coll Cardiol 2000,36 693- 8
519   Mandak JS, Blankenship JC, Gardner LH, et al Modifiable risk factors for vascular access site complications in the IMPACT II Trial of angioplasty with versus without eptifibatide Integnhn to Mim-mize Platelet Aggregation and Coronary Thrombosis J Am CollCardiol 1998,31 1518-24
520   Aguirre FV, Topol EJ, Ferguson JJ, et al  Bleeding complications with the chimenc antibody to platelet glycoprotein Ilb/IIIa integrin in patients undergoing percutaneous coronary intervention EPIC Investigators Circulation 1995,91 2882-90
521   Blankenship JC, Hellkamp AS, Aguirre FV, Demko SL, Topol EJ, Califf RM Vascular access site complications after percutaneous coronary intervention with abciximab in the Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) trial Am J Cardiol 1998,81 36-40
522  Laarman GJ, Kiemeneij F, van der Wieken LR, Tijssen JG, Suwarganda JS, Slagboom T A pilot study of coronary angioplasty in outpatients Br Heart J 1994,72 12-5
523  Cragg DR, Friedman HA, Almany SL, et al Early hospital discharge after percutaneous transluminal coronary angioplasty Am J Cardiol 1989,64 1270-4
524  Johnson LW, Esente P Giambartolomei A, et al Peripheral vascular complications of coronary angioplasty by the femoral and brachial techniques  Cathet Cardiovasc Diagn 1994 31 165-72
525  Skillman JJ, Kim D, Bairn DS Vascular complications of percutaneous femoral cardiac interventions incidence and operative repair Arch Surg 1988,123 1207-12
526   Khoury M, Batra S, Berg R, Rama K, Kozul V Influence of arterial access sites and interventional procedures on vascular complications after cardiac cathetenzations Am J Surg 1992,164 205-9
527   Kresowik TF, Khoury MD, Miller BV, et al A prospective study of the incidence and natural histoiy of femoral vascular complications after percutaneous transluminal coronaiy angioplasty J Vase Suig 1991 13 328 -33, discussion 333-5
528   Lumsden AB  Miller JM, Kosinski AS, et al  A prospective evaluation of surgically treated gioin complications following percutaneous caidiac procedures   Am Suig 1994 60 132-7
529   Muller DW, Shamir KJ, Ellis SG, Topol EJ  Peripheral vascular complications after
conventional and complex percutaneous coronary interventional procedures Am J Cardiol
1992,69 63-8
530   Agrawal SK, Pinheiro L, Roubin GS, et al   Nonsurgical closure of femoral
pseudoaneurysms complicating cardiac cathetenzation and percutaneous transluminal
coronary angioplasty J Am Coll Cardiol 1992,20 610 -5
531  Bogart DB, Bogart MA, Miller JT, Farrar MW, Barr WK, Montgomery MA Femoral
artery cathetenzation complications a study of 503 consecutive patients Cathet Cardiovasc
Diagn 1995,34 8-13
532   Kent КС, Moscucci M, Mansour KA, et al Retropentoneal hematoma after cardiac
catheterization prevalence, risk factors, and optimal management J Vase Surg 1994,20 905-
10, discussion 910-3
533   Feld R, Patton GM, Carabasi RA, Alexander A, Merton D, Needleman L Treatment ol
latrogenic femoral artery injuries with ultrasound- guided compression  J Vase Surg
1992,16 832-40
534   Schaub F, Theiss W, Heinz M, Zagel M, Schomig A New aspects in ultrasound-
guided compression repair of postcathetenzation femoral artery injuries  Circulation
1994,90 1861-5
535   Kim D, Orron DE, Skillman JJ, et al Role of superficial femoral artery puncture in the
development of pseudoaneurysm and arteno-venous fistula complicating percutaneous
transfemoral cardiac cathetenzation Cathet Cardiovasc Diagn 1992,25 91-7
536   Sanborn ТА, Gibbs HH, Bnnker JA, Knopf WD, Kosinski EJ, Roubin GS A multicenter
randomized trial companng a percutaneous collagen hemostasis device with conventional
manual compression after diagnostic angiography and angioplasty J Am Coll Cardiol
1993,22 1273-9
537   Silber S Hemostasis success rates and local complications with collagen after femoral
access for cardiac catheterization   analysis of 6007 published patients   Am Heart J
1998,135 152-6
538   Kussmaul WG, Buchbinder M, Whitlow PL, et al Femoral artery hemostasis using an
implantable device (Angio-Seal) after coronary angioplasty Cathet Cardiovasc Diagn
1996,37 362-5
539   Kuntz RE, Piana R, Pomerantz RM, et al Changing incidence and management of
abrupt closure following coronary intervention in the new device era Cathet Cardiovasc
Diagn 1992,27 183-90
540   Simpfendorfer C, Belardi J, Bellamy G, Galan K, Franco I, Hollman J Frequency,
management and follow-up of patients with acute coronary occlusions after percutaneous
transluminal coronary angioplasty Am J Cardiol 1987,59 267-9
541   de Feyter PJ, de Jaegrere PP, Serruys PW Incidence, predictors, and management of
acute coronary occlusion alter coronary angioplasty Am Heart J 1994,127 643-51
542   Klein LW, Kramer BL, Howard E, Lesch M Incidence and clinical significance of
transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction
associated with coronary angioplasty J Am Coll Cardiol 1991,17 621-6
543   Kong TQ, Davidson CJ, Meyers SN, Tauke JT, Parker MA, Bonow RO Prognostic
implication of creatine kinase elevation following elective coronary artery interventions
JAMA 1997 277 461-6
544  Myocardial infarction redefined a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocar­dial infarction J Am Coll Cardiol 2000 36 959 -69
545  Aguilar C, Reza A, Garcia JE, Rull JA Biguanide related lactic acidosis incidence and risk factors Arch Med Res 1992,23 19-24
546  Smith SC, Jr, Blair SN, Cnqui MH, et al Preventing heart attack and death in patients with coronary disease Circulation 1995,92 2-4
547   Yusuf S, Sleight P, Pogue J, Bosch JDR, Dagenais G Effects of an angiotensin-convertingenzyme inhibitor, ramipnl, on cardiovascular events in hight-nsk patients The Heart Outcomes Prevention Evaluation Study Investigators   N Engl J Med 2000,342 145-53
548  Pfeifer MA, Braunwald E, Moye LA, et al Effect of captopnl on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction Results of the sur­vival and ventricular enlargement trial The SAVE Investigators N Engl J Med 1992,327 669-77
549  Gibbons RJ, Balady GJ, Beasley JW, et al ACC/AHA guidelines for exercise testing executive summary a report of the American College of Cardiology/American Heart Asso­ciation Task Force on Practice Guidelines (Committee on Exercise Testing) J Am Coll Cardiol 1997,30 260-315
550  Bengtson JR, Mark DB, Honan MB, et al Detection of restenosis after elective percuta­neous transluminal coronary angioplasty using the exercise treadmill test  Am J Cardiol 1990,65 28-34
551   Kadel C, Strecker T, Kaltenbach M, Kober G Recognition ofrestenosis can patients be defined in whom the exercise-ECG result makes angiographic restudy unnecessary9 Eur Heart J 1989,10 Suppl G 22-6
552  Schroeder E, Marchandise B, De Coster P, et al Detection ofrestenosis after coronary angioplasty for single-vessel disease how reliable are exercise electrocardiography and scin-tigraphy in asymptomatic patients9 Eur Heart J 1989,10 Suppl G 18-21
553  Honan MB, Bengston JR, Pryor DB, et al Exercise treadmill testing is a poor predictor of anatomic restenosis after angioplasty for acute myocardial infarction   Circulation 1989,80 1585-94
554   Laarman GJ, Luijten HE, van Zeyl LG, et al  Assessment of "silent" restenosis and long-term follow-up after successful angioplasty in single vessel coronary artery disease the value of quantitative exercise electrocardiography and quantitative coronary angiography J Am Coll Cardiol 1990,16 578 -85
555   el-Tamimi H, Davies GJ, Hackett D, Fragasso G, Crea F, Masen A Very early predic­tion ofrestenosis after successful coronary angioplasty anatomic and functional assessment J Am Coll Cardiol 1990,15 259 -64
556  Roth A, Miller HI, Keren G, et al Detection ofrestenosis following percutaneous coronary angioplasty in single-vessel coronary disease the value of clinical assessment and exercise tolerance testing Cardiology 1994 84 106-13
557  Desmet W, De Scheerdei I, Piessens J Limited value of exercise testing in the detection of silent restenosis after successful coronary angioplasty Am Heart J 1995,129 452-9
558  Vlay SC Charnilas J, Lawson WE, Dervan JP Restenosis after angioplasty don't rely on the exercise test Am Heart J 1989 117 980-6
559   Pepine CJ, Cohn PF, Deedwania PC, et al Effects of treatment on outcome in mildly
symptomatic patients with ischemia during daily life the Atenolol Silent Ischemia Study
Circulation 1994,90 762- 8
560   Ritchie JL, Bateman TM, Bonow RO, et al  Guidelines for clinical use of cardiac
radionuchde imaging report of the American College of Cardiology/American Heart Asso­
ciation Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures
(Committee on Radionuchde Imaging), developed in collaboration with the American Soci
ety of Nuclear Cardiology J Am Coll Cardiol 1995,25 521-47
561  Hecht HS, Shaw RE, Chin HL, Ryan C, Stertzer SH, Myler RK Silent ischemia after
coronary angioplasty evaluation of restenosis and extent of ischemia in asymptomatic pa­
tients by tomographic thalhum-201 exercise imaging and comparison with symptomatic pa­
tients J Am Coll Cardiol 1991,17 670-7
562   Cheithn MD, Alpert JS, Armstrong WF, et al  ACC/AHA guidelines for the clinical
application of echocardiography a report of the American College of Cardiology/American
Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of
Echocardiography)   Developed in collaboration with the American Society of
Echocardiography Circulation 1997,95 1686-744
563   Hecht HS, DeBord L, Shaw R, et al Usefulness of supine bicycle stress echocardiography
lor detection of restenosis after percutaneous transluminal coronary angioplasty Am J Cardiol
1993,71 293-6
564   Fioretti PM, Pozzoh MM, Ilmer B, et al Exercise echocardiography versus thalhum-
201 SPECT for assessing patients before and after PTC A Eur Heart J 1992,13 213-9
565   Pirelli S, Danzi GB, Alberti A, et al  Comparison of usefulness of high-dose dipy-
ndamole echocardiography and exercise electrocardiography for detection of asymptomatic
restenosis after angioplasty Am J Cardiol 1991,67 1335- 8
566   Rozenman Y, Gilon D, Zehngher J, et al One-stage coronary angiography and angioplasty Am J Cardiol 1995,75 30-3
567   Adele C, Vaitkus PT, Wells SK, Zehnacker JB Cost advantages of an ad hoc angioplasty
strategy J Am Coll Cardiol 1998,31 321-5
568   Breisblatt WM, Ruffner RJ, Uretsky BF, Reddy PS Sameday angioplasty and diagnostic
cathetenzation safe and effective but riskier in unstable angina Angiology 1991,42 607-13
569   Clark VL, Dolce J Unplanned admissions after outpatient cardiac cathetenzation Clin
Cardiol 1993,16 823-6
570   O'Keefe JH , Jr, Gernon C, McCalhster BD, Ligon RW, Hartzler GO Safety and cost
effectiveness of combined coronary angiography and angioplasty Am Heart J 1991,122 50 -4
571   O'Keefe JH , Jr, Reeder GS, Miller GA, Bailey KR, Holmes DR, Jr Safety and efficacy
of percutaneous transluminal coronary angioplasty performed at time of diagnostic
cathetenzation compared with that performed at other times Am J Cardiol 1989,63 27-9
572   Kimmel SE, Berlin JA, Hennessy S, Strom BL, Krone RJ, Laskey WK Risk of major
complications from coronary angioplasty performed immediately after diagnostic coronary
angiography results from the Registry of the Society for Cardiac Angiography and Interven­
tions J Am Coll Cardiol 1997,30 193-200
573        Alfonso F, Macaya C, Iniguez A, Zarco P Repeat coronary angioplasty during the same angiographic diagnosis oi coronary restenosis Am Heart J 1990 119 237-41
574  Myler RK, Stertzer SH, Clark DA, Shaw RE, Fishman-Rosen J, Murphy MC Coronary angioplasty at the time of initial cardiac cathetenzation "ad hoc" angioplasty possibilities and challenges Cathet Cardiovasc Diagn 1986,12 213-4
575   Barnathan ES, Schwartz JS, Taylor L, et al Aspirin and dipyndamole in the preven tion of acute coronary thrombosis complicating coronary angioplasty  Circulation 1987,76 125-34
576  Halle AA, III, Wilson RF, Massin EK, et al Coronary angioplasty in cardiac transplant patients results of a multicenter study Circulation 1992,86 458-62
577   Heublein B, Pethig K, Maass C, Wahlers T, Havench A Coronary artery stenting in cardiac allograft vascular disease Am Heart J 1997,134 930 -8
578   Pande AK, Gossehn G, Rashdan I, Carrier M, Leung TK, Bonan R  Coronary angioplasty in the treatment of postcardiac transplant coronary artery disease J Invas Cardiol 1996,8 252-6
579  Sandhu JS, Uretsky BF, Reddy PS, et al Potential limitations of percutaneous transluminal coronary angioplasty in heart transplant recipients Am J Cardiol 1992,69 1234 -7
580   von Scheldt W, Uberfuhr P, Reichart B, Steinbeck G  The role of PTCA in the management of focal critical lesions in transplant coronary artery disease Transplant Proc 1995,27 1936-8
581   Swan JW, Norell M, Yacoub M, Mitchell AG, Ilsley С Coronary angioplasty in cardiac transplant recipients Eur Heart J 1993,14 65- 70
582  Quigley PJ, Hlatky MA, Hinohara T, et al Repeat percutaneous transluminal coronary angioplasty and predictors of recurrent restenosis Am J Cardiol 1989,63 409 -13
583  Bauters C, Lablanche JM, Leroy F, Bertrand ME Treatment of first restenosis by recurrent angioplasty immediate results and angiographic follow-up after 6 months Arch Mai Coeur Vaiss 1992,85  1515-20
584   Glazier JJ, Varncchione TR, Ryan TJ, Ruocco NA, Jacobs AK, Faxon DP Factors predicting recurrent restenosis after percutaneous transluminal coronary balloon angioplasty Am J Cardiol 1989,63 902-5
585  Teirstein PS, Hoover С A, Ligon RW, et al Repeat coronary angioplasty efficacy of a third angioplasty for a second restenosis J Am Coll Cardiol 1989,13 291- 6
586   Dehgonul U, Vandormael M, Kern MJ, Galan К Repeat coronary angioplasty for restenosis results and predictors of follow-up clinical events Am Heart J 1989,117 997-1002
587  Bauters C, Lablanche JM, McFadden EP, Leroy F, Bertrand ME Clinical characteristics and angiographic follow-up of patients undergoing early or late repeat dilation for a first restenosis J Am Coll Cardiol 1992,20 845- 8
588  Bauters C, Lablanche JM, Leroy F, Beitrand ME Morphological changes of coronary stenosis after repeated balloon angioplasties  a quantitative angiographic study Cathet Cardiovasc Diagn 1991,24  158-60
589  Henderson RA, Pipihs A, Cooke R, Timmis AD, Sowton E Angiographic morphology of recurrent stenoses after percutaneous transluminal coronary angioplasty are lesions longer at restenosis? Int J Card Imaging 1990,6 77- 84
590  Kitazume H, Ichiro K, Iwama T, Ageishi Y Repeat coronary angioplasty as the treat­ment of choice for restenosis Am Heart J 1996,132 711-5
591  Reeder GS, Bresnahan JF, Holmes DR, Jr, Litvack F Excimer laser coronary angioplasty
results in restenosis versus de novo coronary lesions Excimer Laser Coronary Angioplasty
Investigators Cathet Cardiovasc Diagn 1992 25 195-9
592   Erbel R, Haude M, Hopp HW, et al Coronary-artery stenting compared with balloon
angioplasty loi restenosis after initial balloonangioplasty Restenosis Stent Study Group N
Engl J Med 1998,339  1672-8
593   Mehta VY, Jorgensen MB, Raizner AE, Wolde-Tsadik G, Mahrer PR, Mansukham P
Spontaneous regression of restenosis an angiographic study J Am Coll Caidiol 1995,26 696
-702
594   Serruys PW, Emanuelsson H, van der Giessen W, et al Hepann-coated Palmaz-Schatz
stems in human coronary arteries early out-come of the Benestent II Pilot Study Circulation
1996,91412-22
595   Dussaillant GR, Mint7 GS, Pichard AD, et al Small stent size and intimal hyperplasia
contribute to lestenosis a volumetric intravascular ultrasound analysis J Am Coll Cardiol
1995,26 720-4
596   Serruys PW, Kay IP, Disco C, Deshpande NV, de Feyter PJ Penprocedural quantitative
coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at
six months results of a meta-analysis of the BElgian NEtherlands Stent study (BENESTENT)
I, BENESTENT II Pilot, BENESTENT II and MUSIC trials Multicenter Ultrasound Stent
In Coronanes J Am Coll Cardiol 1999,34 1067-74
597   Ellis SG, Savage M, Fischman D, et al Restenosis after placement of Palmaz-Schatz
stents in native coronary arteries  initial results of a multicenter experience  Circulation
1992,86 1836-44
598   Kereiakes DJ, Midei M, Hermiller J, et al  Procedural and late outcomes following
MULTI LINK DUET coronary stent deployment Am J Cardiol 1999,84 1385-90
599   Hoffmann R, Mintz GS, Dussaillant GR, et al Patterns and mechanisms of in stent
restenosis a serial intravascular ultrasound study Circulation 1996,94 1247-54
600   Hoffmann R, Mintz GS, Kent KM, et al Serial intravascular ultrasound predictors of
restenosis at the margins of Palmaz-Schatz stents Am J Cardiol 1997,79 951-3
601   Mehran R, Mintz GS, Popma JJ, et al Mechanisms and results of balloon angioplasty
for the tieatment of m-stent restenosis Am J Cardiol 1996,78 618 -22
602   Bairn DS, Levine MJ, Leon MB, Levine S, Ellis SG, Schatz RA  Management of
restenosis within the Palmaz-Schatz coronary stent (the U S multicenter experience) The
U S Palmaz Schatz Stent Investigators Am J Cardiol 1993,71 364 -6
603   Macander PJ, Roubin GS, Agrawal SK, Cannon AD, Dean LS, Baxley WA Balloon
angioplasty for treatment of m-stent restenosis   feasibility, safety, and efficacy Cathet
Cardiovasc Diagn 1994,32  125-31
604   Gordon PC, Gibson CM, Cohen DJ, Carrozza JP, Kuntz RE, Bairn DS Mechanisms of
restenosis and redilation within coronary stents quantitative angiographic assessment J Am
Coll Cardiol 1993,21   1166-74
605   Rcimeis B, Moussa I, Akiyama T, et al Long-term clinical follow-up after successful
repeat peicutaneous intervention for stent restenosis J Am Coll Cardiol 1997,30 186 -92
606   Mehian R, Dangas G, Abizaid AS, et al Angiographic patterns of in stent restenosis
classification and implications for long teim outcome Circulation 1999,100 1872-78
607   Meyei 1 Schmidt T, Buchwald A, Wiegand V Stent wire cutting during coronaiy dnec
tional atheiectomy Chn Cardiol 1993,16 450-2
608  Strauss BH, Umans VA, van Suylen RJ, et al Directional atherectomy lor treatment of restenosis within coronary stents clinical, angiographic and histologic results J Am Coll Cardiol 1992 20  1465-73
609  Bottner RK, Hardigan KR High-speed rotational ablation for m-stent restenosis Cathet Cardiovasc Diagn 1997,40 144-9
610   Stone GW Rotational atherectomy for treatment of m-stent restenosis   role of intracoronary ultrasound guidance Cathet Cardiovasc Diagn 1996,Suppl 3 73-7
611   Hara K, Ikan Y, Tamura T, Yamaguchi T Transluminal extraction atherectomy for restenosis following Palmaz-Schatz stent implantation Am J Cardiol 1997,79 801-2
612  Patel JJ, Meadaa R, Cohen M, Adiraju R, Kussmaul WG, Til Transluminal extraction atherectomy for aortosaphenous vein graft stent restenosis  Cathet Cardiovasc Diagn 1996,38 320-4
613   Goods CM, Jain SP, Liu MW, Babu RB, Roubin GS Intravascular ultrasound guided transluminal extraction atherectomy for restenosis after Gianturco-Roubin coronary stent implantation Cathet Cardio-vasc Diagn 1996,37 317-9
614  Virk SJ, Bellamy CM, Perry RA Transluminal extraction atherectomy for stent restenosis in a saphenous vein bypass graft [letter] Eur Heart J 1997,18 350 -1
615   Ikan Y, Yamaguchi T, Tamura T, Isshiki T, Saeki F, Нага К Transluminal extraction atherectomy and adjunctive balloon angioplasty for restenosis after Palmaz-Schatz coronary stent implantation Cathet Cardiovasc Diagn 1993,30 127-30
616   Chow WH, Chan TF Pullback atherectomy for the treatment of intrastent restenosis [letter] Cathet Cardiovasc Diagn 1997,41 94-5
617  Cecena FA Stenting the stent alternative strategy for treating m-stent restenosis Cathet Cardiovasc Diagn 1996,39 377- 82
618  Debbas N, Stauffer JC, Eeckhout E, Vogt P, Kappenberger L, Goy JJ Stenting within a stent treatment for repeat m-stent restenosis in a venous graft Am Heart J 1997,133 460 -3
619   Moris C, Alfonso F, Lambert JL, et al Stenting for coronary dissection after balloon dilation of m-stent restenosis stenting a previously stented site Am Heart J 1996,131 834-6
620   Waksman R, Bhargava B, Mintz GS, et al  Late total occlusion after intracoronary brachytherapy for patients with m-stent restenosis J Am Coll Cardiol 2000,36 65- 8
621   Murray CJ, Lopez AD, Jamison DT The global burden of disease in 1990 summary results, sensitivity analysis and future directions Bull World Health Organ 1994,72 495-509
622  Cohen DJ, Sukin CA Cost-effectiveness of coronary interventions Heart 1997,78 Suppl 2 7-10
623  Gold MR, Siegel JE, Russell LB, Weinstein MC In Gold MR, editor Cost-Effective ness in Health and Medicine NY Oxford University Press, 1996
624   Wong JB, Sonnenbeig FA, Salem DN, Paukei SG Myocardial levasculanzation for chiomc stable angina analysis of the role of percutaneous transluminal coronary angioplasty based on data available m 1989 Ann Intern Med 1990,1 П 852-71
625  Cohen DJ, Breall JA Ho KK, et al Evaluating the potential cost effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease use of a decision analytic model Cumulation 1994 89 1859-74
626   Cohen DJ, Krumholz HM, Sukm CA, et al  In-hospital and one year economic out­
comes after coronary stenting or balloon angioplasty  results from a randomized clinical
trial Stent Restenosis Study Investigators Circulation 1995,92 2480-7
627   Kuntz KM, Tsevat J, Goldman L, Weinstein MC Cost-effectiveness of routine coronary
angiography after acute myocardial infarction Circulation 1996,94 957- 65
628   Sim I, Gupta M, McDonald K, Bourassa MG, Hlatky MA A meta-analysis of randomized
trials comparing coronary artery bypass grafting with percutaneous transluminal coronary
angioplasty in multivessel coronary artery disease Am J Cardiol 1995,76 1025-29
629   Weintraub WS, Mauldin PD, Becker E, Kosinski AS, King SB, III A comparison of the
costs of and quality of life after coronary angioplasty or coronary surgery for multivessel
coronary artery disease results from the Emory Angioplasty Versus Surgery Trial (EAST)
Circulation 1995,92 2831-40
 
 
 
  
, 
 


Все для вашего сердца - все разделы сайта
Для всех: Начало | Кто мы |  Мы рекомендуем 
Для пациентов: Ишемия миокарда | диагностика | Лечение | Хирургия | Терапия | Профилактика  | Памятка пациенту | После операции |
Как получить консультацию | Анализы до операции |
;Для врачей:

Коронарное шунтирование | Ангиопластика | Показания к интервенционной тактике | Оригиналы руководств, ссылки |
Шкала оценки риска | Приказ МЗ РФ N 220 | Регистрация |

Публикация материалов только с разрешения администрации сайта


Коронарное шунтирование. Коронарная ангиопластика. Коронарография

Телефон горячей линии по коронарному шунтированию: (495) 225 52 54